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Foreword 
Prof. Dr.med. Ulrich Keller 
President of the Federal Commission for Nutrition (FCN)  
 
Switzerland is an iodine deficient area, and iodine has been added to table salt since 1922. 
To ensure sufficient iodine intake in Switzerland, iodine supply is continuously monitored at 5 year 
intervals since 1999. Iodine supply is surveyed by the Iodine-Fluoride Committee of the Swiss 
Academy of Medical Sciences, formerly the Swiss Commission on Goiter. 
Based on the monitoring, the amount of iodine that is added to table salt can be adjusted if needed. 
The importance of this strategy has increased due to the changing eating habits of today’s society, 
with more and more meals consumed out of home, and due to the internationalization of the food 
market. Imported convenience foods or domestic cheese may have been prepared with non-iodinated 
salt, and the current trend to reduce salt consumption by adding less salt e.g. to bread further 
endanger sufficient iodine supply for the population. 
The last monitoring was performed in 2009 and it appears that an increasing part of high risk groups 
(pregnant and lactating women, young children) are at risk to be iodine deficient. Therefore, the 
Federal Commission on Nutrition asked the Federal Office of Public Health to support the production 
and publication of an expert report on iodine supply in Switzerland. 
This report has now been completed, and it has been ratified by the members of the FCN. 
We would like to thank the authors, and in particular the president of the working group, Prof. Michael 
Zimmermann, ETH Zurich, for their outstanding contributions. 
This report should provide the background for an adjustment of iodine supplementation of Swiss table 
salt, and it should provide valuable informations for the food industry, for people teaching human 
nutrition and for public health experts. Last but not least, it should improve iodine supply particularly to 
persons with increased risk of inadequate provision, thereby preventing adverse effects of iodine 
deficiency. 
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Executive Summary 
Prof. Dr.med. Michael B. Zimmermann 
President of the Iodine/Fluoride Committee of the Swiss Academy of Medicine 
 
Historically, Switzerland was a country of severe endemic goiter and cretinism. In 1922, Eggenberger, 
chief surgeon at the hospital in Herisau, introduced iodized salt into the Canton of Appenzell 
Ausserrhoden. Within one year, goiter size was sharply reduced in affected children. Recognizing the 
enormous public health benefit, the United Swiss Rhine Salt Works began to produce iodized salt and 
the Swiss Federal Office of Public Health formed the Swiss Goiter Commission in 1922. This 
Commission proceeded cautiously with iodine fortification, raising the iodine content of Swiss salt in 
four steps over a period of 90 years, from 3.75 ppm to the current level of 20 ppm. The goiter rate in 
school-age children is now below 5% and no new cretins have been born since 1930. In 2012, the 
Swiss iodized salt program remains a model for many other countries. Chapter 3 of this report briefly 
summarizes the history of Swiss iodine prophylaxis.  
Iodine is essential for normal growth and development because it is an essential component of the 
thyroid hormones. Because thyroid hormones regulate normal fetal growth and brain development, in 
utero iodine deficiency can irreversibly damage the offspring. Thus, it is critical to provide ample 
dietary iodine during pregnancy (requirements are 250 µg/day), a 50% increase compared to pre-
pregnancy (150 µg/day). Infants are born with very limited thyroidal iodine stores and are dependent 
on a steady supply of dietary iodine. Breast milk or infant formula should provide at least 90 µg of 
iodine per day to cover infant requirements. Breastfed infants of iodine sufficient mothers obtain 
adequate iodine from breast milk and do not need supplemental sources of iodine. Because dairy 
products and iodized salt are the major sources of iodine in the Swiss diet, weaning infants fed only 
complementary foods without added salt are at risk of iodine deficiency. Once the infant has weaned 
from breast milk and is beginning to eat other foods, provision of iodine-fortified complementary foods, 
follow-on formula containing iodine and/or home-prepared foods containing iodized salt, may be 
important to meet their iodine requirements. Mild-to-moderate iodine deficiency during later childhood 
can impair cognitive function and learning, and recent controlled trials of iodine repletion in school-
aged children have shown benefits on cognitive and motor test performance. Thus, pregnant and 
lactating women, infants and children are important target groups for iodine prophylaxis in the Swiss 
population. Chapters 1 and 2 of this report describe the effects of iodine deficiency on pregnant and 
lactating women, as well as infants and children.  
In Switzerland, the Federal Office of Public Health measures the content of iodine in food groups to 
identify and quantify major sources of dietary iodine in the population. Nearly all foods, with the 
exception of marine fish, contain very low amounts of iodine. Milk and milk products are important 
sources of iodine in the Swiss diet, because iodine is introduced via supplements given to dairy cows 
(particularly in winter). The other main sources of iodine in the Swiss diet are bread and baked goods, 
because many bakeries voluntarily use iodized salt. The iodine concentration in other foodstuffs, such 
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as meat, vegetables and fruits, is extremely low. Cheese could be an important source of iodine in 
Switzerland, because of the iodine content of milk and iodized salt added during production. Yet most 
Swiss cheese producers have discontinued the use of iodized salt for two main reasons: 1) the 
inability to export products to France containing added iodine; and 2) the new Swiss 
‘Deklarationspflicht’ that specifies that cheese containing iodized salt must have an ingredient label, 
whereas cheese containing non-iodized salt need not have a label of ingredients.  
Use of iodized salt by Swiss households remains high, at greater than 80%, but use of iodized salt in 
industrially processed foods may be decreasing. In Switzerland, iodized salt consumed from home-
cooked food contributes only a small proportion of the total iodine intake since most salt consumption 
is from processed foods. Thus, use of iodized salt by the food industry is critical and must be strongly 
promoted. Therefore, when considering changes to the iodine content of Swiss salt to increase dietary 
iodine intake in the population, the focus should be on the food industry rather than only household 
salt. The Swiss Federal Office of Public Health estimates an adult following the dietary 
recommendations of the Swiss Society for Nutrition will have a mean iodine intake of approximately 
145 µg/day, near the adult requirement of 150 µg/day. However, people following restrictive eating 
behaviors, such as a strict vegan diet without milk or eggs, may be at risk of iodine deficiency, 
particularly if they do not use iodized salt. Nutritional habits, food formulation and production 
procedures are constantly changing, and since all of these factors can influence iodine intakes, regular 
monitoring of iodine nutrition in Switzerland will remain important. Chapter 4 of this report summarizes 
the iodine content of Swiss foods and iodine sources in the Swiss diet. 
In Switzerland, iodine status in target groups is monitored every 5 years through national surveys. The 
main indicator used in these surveys is the urinary iodine concentration (UIC), an excellent biomarker 
of population exposure because most dietary iodine is excreted in the urine in the following 24 hours. 
In the last two national surveys, in 2004 and 2009, the median UIC in school-age children and 
pregnant women indicated sufficient iodine intake. However, iodine intakes fell in these groups 
between 2004 and 2009. In addition, in 2009, infants, lactating women and women of reproductive age 
had borderline low iodine intakes. Thus, although Switzerland is still considered an iodine sufficient 
country, iodine intakes appear to be decreasing in key target groups, and are currently at the lower 
end of the recommended range in pregnant women and children. These monitoring data suggest a 
modest increase in the iodine content of Swiss salt is needed in order to ensure iodine sufficiency in all 
population groups. Chapter 3 of this report describes the recent epidemiology of iodine nutrition in 
Switzerland.  
Current efforts to lower population sodium intake in Switzerland to reduce hypertension do not conflict 
with the salt iodization program; these two important public health policies can be complementary but 
public health messages need to be integrated to avoid confusion. Future reductions in salt intake will 
require adaptations to the Swiss iodized salt program by: 1) ensuring high penetration rate of iodized 
salt in food production; and 2) adjusting iodine fortification levels in salt upward to compensate for 
lower salt intake. Regular monitoring of iodine status should continue in school age children, pregnant 
women and infants. For the latter two groups, if the iodized salt program cannot provide adequate 
iodine intakes, alternative intervention strategies will need to be considered. An effective iodized salt 
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program in Switzerland requires a joint effort of all partners including the Swiss Federal Office of 
Public Health, salt industry, food producers, academia, health professionals and consumer 
organizations. Chapter 5 in this report summarizes the critical role of the food industry, partnerships 
and integration of iodized salt and sodium reduction programs.  
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Conclusions and Recommendations 
1. The long-running Swiss iodized salt program, a model for most other countries, has provided 
adequate iodine to the population for decades. But it is critical not to become complacent.  
2. Sponsored by the Swiss Federal Office of Public Health, the ETH Zurich performs national 
iodine surveys every 5 years since 1999. In the last two surveys, in 2004 and 2009, the 
median urinary iodine concentration in school-age children and pregnant women indicated 
sufficient iodine intake. However, iodine intakes fell in these groups between 2004 and 2009, 
and are currently at the lower end of the recommended range. In the 2009 survey, infants, 
lactating women and women of reproductive age had borderline low iodine intakes (Chapter 3 
of this report). Thus, at the current fortification level of 20 ppm iodine in salt in Switzerland, 
iodine intakes are borderline sufficient. To ensure iodine sufficiency in all population groups, it 
would be prudent to increase the iodine concentration in Swiss salt to 25 ppm in 2013. 
3. The current median UICs in school children and pregnant women in Switzerland are 120 µg/L 
and 162 µg/L. These medians are far below the WHO-recommended thresholds for excessive 
iodine intake based on the median UIC in these two groups of 300 µg/L and 500 µg/L, 
repectively. Also, the percentage of Swiss school children with a UIC above the UL of 
300 µg/day is <1%. Thus, the current iodized salt program is not placing the Swiss population 
at risk for iodine excess. If the iodine content in Swiss salt were to increase ca. 20% (i.e. if the 
iodine level is increased from 20 to 25 ppm in 2013), there would still be very low risk of iodine 
excess. WHO/ICCIDD currently recommend to set salt iodization levels in national programs in 
the range of 20 to 40 ppm (18), and the Swiss fortification level is at the lower end of this 
recommended range. 
4. Because overall, Swiss pregnant women are iodine sufficient, routine iodine supplementation 
during pregnancy is not needed for healthy women eating typical Swiss diets. But for those 
Swiss pregnant women who may have low iodine intakes because they do not use iodized 
salt, a prenatal supplement containing 150-200 µg iodine per day is advisable. Most prenatal 
supplements available in Switzerland do not contain iodine. Supplement manufacturers should 
be encouraged to include iodine in their prenatal products so that pregnant women with diets 
low in iodine can obtain adequate iodine intake. Swiss pregnant women who are consuming 
iodized salt can also safely consume a prenatal iodine supplement containing 150-200 µg 
iodine per day. 
5. Breast milk is the most important iodine source during infancy and lactating women should be 
advised to consume iodized salt and choose foods produced with iodized salt. Breastfed 
infants of iodine sufficient mothers obtain adequate iodine from breast milk and do not need 
supplemental sources of iodine. Once the infant has weaned from breast milk and is beginning 
to eat other foods, provision of iodine-fortified complementary foods, follow-on formula 
containing iodine and/or home-prepared foods containing iodized salt, may be important to 
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meet their iodine requirements. In home-prepared infant foods, salt should only be added 
beginning in the second year and only added in moderation. The salt used should be iodized. 
6. Dietary iodine supply in Switzerland is influenced by many hidden factors, use of iodized salt 
by Swiss households and the food industry is voluntary, and changes in industrial practices 
and trade legislation can reduce dietary iodine supply. Therefore, regular surveys of iodine 
status in Switzerland are necessary to ensure adequacy in the face of not-always-predictable 
changes in salt and food consumption practices. It is essential to continue the national iodine 
surveys at 5 year intervals, and include functional indicators of thyroid status where 
appropriate (e.g., serum thyroglobulin, newborn TSH) to ensure coverage the key target 
groups.  
7. Iodized salt consumed from home-cooked food contributes only a small proportion of the total 
iodine intake since most of salt consumption in Switzerland comes from processed foods. 
Therefore, it is critical that the Swiss food industry continue to use iodized salt in their 
products. To achieve this, strong and sustained advocacy toward the food industry from the 
Swiss government and other concerned groups is important. Also, if required, the Federal 
Office of Public Health should provide technical training and assistance to the food industry to 
establish quality control procedures to monitor the use of iodized salt in the food production 
and analytical procedures to measure iodine content in food. 
8. Public health recommendations and dietary guidelines now encourage people to reduce their 
salt intake for cardiovascular health, and this could have a detrimental effect on iodine intakes 
of the Swiss population, as fortified salt is the main dietary source of iodine. These two 
important public health policies can be complementary but it is important they be integrated. 
Concurrent monitoring of sodium and iodine intakes could be implemented. If salt intakes fall, 
this will require adaptations to the Swiss iodine program, including: 1) ensuring the highest 
possible penetration rate of iodized salt in food production; and 2) adjusting the iodine 
fortification levels in salt to compensate for the lower salt intake.  
9. Commercially produced bread is the most important source of dietary iodine in Switzerland. 
However, bread contains relatively high concentrations of salt and is therefore a target for salt 
reduction. However, an increase in the salt iodine concentration could compensate for a 
decrease of the salt content in bread.  
10. Future priorities in research to inform and optimize the Swiss iodized salt program include: 
a) Accurately assess the extent of iodized salt use in Swiss food production, and incorporate 
information on the native iodine content and the iodized salt content in Swiss foods into 
the Swiss Food Composition Database;  
b) Adapt the protocol of the upcoming Swiss National Nutrition Survey to include salt and 
iodine intake so that the dietary data collected can be used in model analysis to predict 
changes in salt and iodine intake;  
c) Better define the requirements for iodine in pregnant and lactating women and young 
infants by using prospective longitudinal studies.  
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11. Future priorities in the area of public policy should include:   
a) Promote use of iodized salt in production of all foods, including its use in business and 
school cafeterias  
b) Make necessary adjustments to iodine levels in salt based on the population’s salt intake 
patterns;  
c) Ensure adequate iodine intakes in vulnerable groups, i.e. infants, children, pregnant 
women and lactating women;  
d) Evaluate the need for iodine supplementation of pregnant and lactating women;  
e) Promote the inclusion of iodine in all prenatal supplements to ensure adequate intakes in 
pregnancy along with intakes from iodized salt (recommendation 4 above) 
f) Evaluate the need to develop a separate policy for iodine fortification of infant formula 
and complementary foods.  
12. Future priorities in political commitment and legislation should include:  
a) Support coordinated European efforts to raise the priority of iodine nutrition on the 
political agenda in Europe and support a common EU policy for the use of iodized salt by 
the food industry. 
13. Future priorities in building partnership should include:  
a) Ensure continued participation of government partners, national agencies, nongovern-
mental organizations, salt producers, academia and the health-care sector in the Swiss 
Fluoride/Iodine Committee;  
b) Provide support and continue the mandate of the Swiss Fluoride/Iodine Committee to 
review information from monitoring activities for planning and promotion of collaborative 
work between the different sectors;  
c) Encourage greater participation of food industry and consumer organizations. 
14. Future priorities in advocacy and communication should include:  
a) Promote the use of iodized salt in all food production and all households;  
b) Develop appropriate communication through mass media, the health system, food 
industry organizations, and other context specific channels to educate the public, salt 
producers and food producers about the importance of iodine nutrition and iodized salt;   
c) Provide support to the Schweizer Rheinsalinen AG to increase the demand for iodized 
salt from the food industry;  
d) Information campaigns of iodine nutrition should be combined with and integrated into 
salt reduction campaigns; advocacy should combine messages on the benefits of salt 
reduction and adequate iodine intake.  
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Chapters of the Report 
1. Iodine in pregnancy, lactation and infancy, and the 
importance of iodine in weaning foods 
 
Dr. med. Katharina Quack Lötscher 
The author declares no conflict of interest. 
1.1. Summary 
Thyroid hormones are essential for normal fetal brain development and fetal growth. Iodine 
requirements are 50% higher in pregnant women than in nonpregnant women due to: i) increased 
maternal thyroid hormone production to maintain maternal euthyroidism; ii) the transfer of thyroid 
hormones and iodine to the fetus, and; iii) an increased maternal renal iodine clearance. Iodine intakes 
in pregnant and lactating women should be 250 µg daily. Infants are born with limited intrathyroidal 
iodine stores and newborns are entirely dependent on dietary iodine. Breast milk or infant formulas 
should provide at least 90 µg of daily iodine to cover the newborn's needs. Breastfed infants of iodine 
sufficient mothers obtain adequate iodine from breast milk and do not need supplemental sources of 
iodine. Because dairy products and iodized salt are the major sources of iodine in the Swiss diet, 
weaning infants fed only complementary foods without added salt are at risk of iodine deficiency. Once 
the infant has weaned from breast milk and is beginning to eat other foods, provision of iodine-fortified 
complementary foods, follow-on formula containing iodine and/or home-prepared foods containing 
iodized salt, may be important to meet their iodine requirements. In home-prepared infant foods, 
iodized salt should only be added beginning in the second year and only added in moderation. 
1.2. Pregnancy 
1.2.1 Iodine and thyroid physiology in pregnancy 
Iodine is an essential component of the thyroid hormones thyroxine (T4) and 3,5,3’-triiodothyronine 
(T3) and gestational iodine requirements increase due to the increased synthesis of thyroid hormones 
during pregnancy. The rising concentrations of estrogens induce an increase in serum thyroxine-
binding globulin (TBG) which reaches a plateau at mid-gestation that lasts until delivery (1) (Figure 1). 
Nuclear receptors for thyroid hormones are only present in the fetal brain after the 9th week of 
gestation, reaching adult levels by the 18th week of gestation (2). At the end of the first trimester, 
placental human chorionic gonadotropin (hCG), which has an intrinsic TSH-like activity, stimulates the 
liver to increase levels of thyroxine-binding proteins, as well as to increase transplacental passage of 
thyroid hormones and increase iodine excretion by the kidney (3). The binding capacity of TBH for T4 
is increased and produces a transient decrease in free T4 concentration, which stimulates further 
production of T4, thereby leading to a new equilibrium (Figure 1). Maternal T3 and T4 levels rise in 
early pregnancy, reach a plateau and subsequently decline over later pregnancy. Around the 
beginning of the second trimester the fetal thyroid begins to produce hormones; however, the full 
14 
 
development of the pituitary-thyroid system in the fetus is not completed until mid-pregnancy. Although 
the T4 concentration in the fetus increases as gestation progresses, the fetal thyroid gland does not 
fully mature until birth and thus maternal thyroid hormones contribute to total fetal thyroid 
concentrations until birth (4).  
 
Figure 1: Conceptual model of the changes in hormones that occur during pregnancy that influence 
iodine requirements. (Adapted from reference (1). E2, estrogen; hCG, human chorionic gonadotrophin; 
TBG, thyroxine-binding globulin; T4, thyroxine. 
 
Both thyroid hormones, T3 and T4, play an important role in the normal growth and development of 
the central nervous system. Despite the placenta acting as a barrier to prevent excessively high levels 
of free T3 and T4, maternal thyroid hormones can be found in embryonic cavities about four weeks 
after conception (2, 5). In the first half of pregnancy, maternal thyroid hormones are the only source for 
fetal cerebral T3, which is generated locally from maternal free T4 in the fetal brain by a type II 5’-
iodothyronin deiodinase (4). In the second half of pregnancy, neurodevelopment remains thyroid 
hormone-dependent and requires an adequate supply of maternal and fetal free T4. This stage 
includes neuronal proliferation and the onset of neuronal migration in the cerebral cortex, 
hippocampus and medial ganglionic eminence, with the latter processes starting in the first trimester 
and continuing into the early part of second trimester (2). 
1.2.2 Iodine requirements 
To produce sufficient thyroid hormone to meet fetal requirements, maternal iodine intake should 
increase by 50% to about 250 µg/day during pregnancy (daily requirements are 150 µg/day for 
nonpregnant women) and the urinary iodine concentration (UIC) should be 150-249 µg/L (13). The 
increase in requirement is due to: i) a 50% rise in maternal thyroid hormone production up to mid-
pregnancy; ii) increased renal blood flow and iodine clearance (30-50%) in the first weeks of gestation; 
and iii) iodine transfer to the fetus, particularly in late gestation (6, 7). These physiological changes 
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tend to lower plasma inorganic iodine (PII) and increase thyroidal clearance of iodine. Insufficient 
dietary intake over an extended period of time may gradually deplete the thyroidal iodine stores (1, 8).  
Because >90% of ingested iodine is excreted in the urine, UIC is an excellent indicator of recent iodine 
intake in all ages (13). UIC can be expressed as a concentration (µg/L), in relationship to creatinine 
excretion (µg iodine/g creatinine), or as 24-hour excretion (µg/day). For populations, because it is 
impractical to collect 24-hour samples in field studies, UI can be measured in spot urine specimens 
from a representative sample of the target group, and expressed as the median, in µg/L.  
1.2.3 Pathology 
If dietary iodine is severely deficient during pregnancy, both the mother and fetus will be at increased 
risk of hypothyroidism. If dietary iodine is moderately deficient during pregnancy, the mother may 
remain euthyroid, but the fetus is at increased risk of hypothyroidism (6). The maternal thyroid gland 
responds to iodine deficiency by hyperplasia and an increase in the trapping of iodine, as well as the 
preferential synthesis of T3 over T4. Thus, maternal TSH and T3 concentrations may fall slightly but 
remain within the normal reference range. But at the same time, because fetal brain T3 is generated 
from maternal T4, local hypothyroxinemia may occur in the developing brain of the fetus, and this is 
likely responsible for the neurodevelopmental damage seen in iodine deficiency (9). Later in 
pregnancy, due to decreased iodine supply to the fetal circulation, there is a decreased synthesis and 
secretion of T3 and T4 by the fetus and this can contribute to fetal hypothyroidism later in pregnancy. 
Since this is associated with a compensatory increase in concentrations of fetal TSH, neonatal TSH 
can be used as index for iodine deficiency in late pregnancy (Guthrie Test). 
Infertility, abortions and stillbirth have been associated with iodine deficiency in areas with severe 
deficiency (10-12). The most severe consequence of in utero iodine deficiency for the offspring is 
cretinism. The neurological form of cretinism is more common than the myxedematous form. The 
putative pathogenesis of neurological cretinism is severe fetal hypothyroidism in the first trimester, and 
includes mental retardation, defects of hearing and speech, squint, impaired voluntary motor activity, 
disorders of stance with spastic gait and ataxia (13).  
Inadequate thyroid hormone production during fetal development impairs myelination, cell migration, 
differentiation and maturation. However, the effect on cognitive function of the offspring in areas with 
mild to moderate iodine deficiency remains unclear. Most earlier studies have focused on thyroid 
dysfunction, independent of iodine status. Haddow et al. in the U.S. found that the IQ scores of 7 to 
9 year old children of mothers with subclinical hypothyroidism during pregnancy (an increased TSH in 
the second trimester) were 4 points lower compared to children from mothers with normal thyroid 
function during pregnancy (14). Pop et al. reported impaired infant development for up to two years in 
children with hypothyroxinemia (free T4 below the 10th percentile at 12 weeks of gestation) compared 
to controls in the Netherlands (15). In both studies, iodine status was not assessed, and both the U.S. 
and the Netherlands were iodine sufficient at the time of the studies. A single small study has 
suggested the prevalence of attention deficit and hyperactivity disorders is higher in the offspring of 
women living in iodine-deficient areas than those in iodine-replete regions (16), but this finding needs 
confirmation.  
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Mild iodine deficiency may lead to lower birth weight. Alvarez-Pedrerol et al. studied the association of 
birth weight and iodine status of 234 Spanish mothers in late pregnancy (17). Women with UIC 
between 100-149 µg/L in the third trimester had a lower risk of having a small-for-gestational-age 
newborn compared to mothers with urinary iodine concentrations below 50 µg/L (adjusted OR : 0.15 
(95% CI: 0.03-0.76)). These results are in line with findings in school- and pre-school children from 
iodine-deficient areas where retarded growth has been observed (18, 19). Preterm newborns are 
particularly vulnerable to hypothyroidism because they no longer benefit from maternal thyroid 
hormones while their own thyroid glands are not yet fully functional (20). The breast milk or infant 
formula of preterm newborns should supply adequate iodine, and in some cases thyroid hormone 
replacement may be necessary. 
1.2.4 Iodine supplementation 
Controlled trials of iodine supplementation (100-200 µg/day) during pregnancy in mild-to-moderate 
iodine deficient areas have reported a significant increase in maternal UIC as well as smaller maternal 
and newborn thyroid glands with iodine, compared to the control group (13). However, none of the 
studies showed a clear effect of iodine supplementation on maternal and newborn total or free thyroid 
hormone concentrations. Thus, available data suggests that, in areas of mild-to-moderate iodine 
deficiency, the maternal thyroid is able to adapt to meet the increased thyroid hormone requirements 
of pregnancy (11), but controlled intervention trials measuring long-term clinical outcomes of mild 
iodine deficiency during pregnancy are now underway. 
Moleti et al. studied the influence of long-term and short-term supplementation with iodized salt in an 
area of mild iodine deficiency (21). They compared the thyroid function of 62 women with regular 
iodized salt intake for at least two years with 38 women who commenced iodized salt consumption 
upon becoming pregnant. The incidence of maternal thyroid failure was six-fold higher in short-term 
users than in long-term users. These findings suggest that the prolonged use of iodized salt before 
pregnancy may increase thyroidal iodine stores and maintain normal maternal thyroid function during 
pregnancy. 
1.2.5 Salt and preeclampsia 
Preeclampsia is a pregnancy disease caused by a dysregulation of the vessels leading to increase of 
blood pressure, proteinuria as well as thrombocytemia. Clinical symptoms are headache and 
progressive oedema. The association with oedema led to the assumption that salt intake may play a 
role in the pathology of preeclampsia. Duley et al. reviewed in 2005 all available studies on the 
influence of salt intake on preeclampsia (22). They found two relevant trials, including 603 women, 
which both compared advice to reduce dietary salt intake with advice to continue a normal diet. The 
confidence intervals were wide and crossed the no-effect line for the risk for preeclampsia (relative risk 
1.11, 95%CI 0.46 - 2.66). The authors concluded that salt consumption during pregnancy should 
remain a matter of personal preference. Thus, salt should not be restricted during pregnancy to reduce 
risk of preeclampsia, and this should not influence intake of iodine from iodized salt.  
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1.2.6 Iodine status in Swiss pregnant women 
In Switzerland, iodine status in pregnancy is monitored every five years in national surveys (23). 
Details of these surveys are given in Chapter 3 of this report; in the last two surveys, in 2004 and 
2009, the median UIC in pregnant women indicated iodine sufficiency. The most commonly used 
prenatal multivitamin supplements in Switzerland do not contain iodine (Table 1). And, as summarized 
in Chapter 3, only a small minority of pregnant women take prenatal supplements containing iodine. 
Therefore, the iodine fortification of Swiss salt supplies pregnant women with sufficient iodine and 
additional iodine supplementation is not recommended at this time for healthy women eating typical 
Swiss diets. However, iodine supplementation during pregnancy appears to be safe, even for those 
women already consuming iodized salt, and does not increase the incidence of post partum thyroid 
dysfunction (24). The effects of increasing iodine intakes in populations and iodine excess are covered 
in detail in Section 3.4 of Chapter 3 of this report. Iodine supplementation during pregnancy is 
recommended in several other countries where iodine intake is borderline sufficient or is deficient, 
including Germany, the U.S., New Zealand and Australia (25). 
 
Table 1: Content of iodine in pregnancy supplements commonly-used in Switzerland. 
Product Iodine content  
(recommended 250ug/day) 
Elevit pronatal© 0 
Vitana© 0 
Andreavit© 200ug 
Gynefam Classic© 150ug 
Femibion 400© 150ug 
Burgerstein© (2 pills) 150ug 
 
1.3. Lactation 
1.3.1 Iodine requirements 
WHO/ICCIDD/UNICEF recommend an intake of 250 µg/day of iodine for lactating women and propose 
a median UIC >100 µg/l in lactating women indicates iodine sufficiency (32). Iodine is secreted into the 
breast milk with a concentration gradient of 20 to 50 times that of plasma levels, through the increased 
expression of the sodium/iodine symporter (NIS) in lactating breast cells (26-28). Colostrum contains 
higher iodine concentrations (approximately 200-400 µg/l) than mature milk (29).  
1.3.2 Iodine concentrations in breast milk 
The iodine content of breast milk in iodine sufficient areas has been reported to be as high as 150-
180 µg/l (33).  However, there is no consensus on the optimal breast milk iodine concentration. An 
Austrian study by Tiran et al. showed that two years consumption of iodized table salt (10-20 ppm) 
doubled the median iodine concentration in breast milk (34). Iodine supplements may increase the 
iodine content of breast milk, although studies are contradictory (35, 36). The supplementation of 
breastfeeding mothers in iodine deficient areas with 150 µg per day of iodine during the first six 
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months of lactation did not increase breast milk iodine levels high enough to meet the requirements of 
the newborn (30). Iodine concentrations in breast milk may vary by infant’s age and the stage of 
lactation. Substantial diurnal and day-to-day variations in breast milk iodine concentrations have been 
reported (31).  
1.3.3 Iodine status during lactation in Switzerland 
As discussed in detail in Chapter 3 of this report, the 2009 national Swiss iodine study included for the 
first time both lactating and non-lactating mothers of 6 to 12 month-old infants (23). Their overall 
median UIC was 75 µg, which may indicate borderline low intake, and was less than half of the 
median UIC in Swiss pregnant women. Only 5% of women reported the use of iodine supplements. 
Not all mothers were still breastfeeding at the time of the study and there was no significant difference 
in the median UIC comparing breastfeeding mothers vs. nonbreastfeeding mothers (67 ug/L, n=196 
vs. 81 µg/L, n=311). The low iodine status of these women can likely be explained by the combined 
high iodine demands of both pregnancy and lactation. The median iodine concentration in breast milk 
in the 2009 survey was 49 µg/kg, somewhat lower than in a previous Swiss study reporting breast milk 
concentrations of 60 - 80 µg/L (22). Thyroid hormone levels were not investigated in the above study.  
1.4. Infancy 
1.4.1 Iodine requirements 
The daily requirements of iodine have been estimated to be at least 15 µg/kg in full term neonates and 
30 µg/kg in preterm infants. A daily intake of 90 µg of iodine is recommended by WHO to cover the 
newborn’s needs (see Table 3 in Chapter 2 of this report) (32). The iodine stores of a newborn are 
small and the thyroidal turnover rate of iodine is more rapid in infants than in adults (13). Therefore, 
during the breastfeeding period, the newborn is nearly completely dependent on iodine intake through 
breast milk and it is critical that mothers have adequate iodine levels. WHO/ICCIDD/UNICEF propose 
a median UIC >100 µg/l in infants indicates iodine sufficiency (32). 
1.4.2 The importance of iodine in weaning foods 
Bottle-fed infants usually have higher UIC levels than exclusively breast-fed infants due to the frequent 
supplementation of iodine in baby formulas (32). As discussed in Chapter 3 of this report, in 
Switzerland in 2009, breast-fed infants had a lower median urinary iodine concentration than non-
breast-fed infants (82 µg/L vs. 105 µg/L; p<0.001) (23). Iodine content in formula is regulated in 
Switzerland by a directive, requiring 10 to 50 µg/100 kcal (33). Andersson et al. tested twelve of the 
most commonly used formula milks in Switzerland and found iodine contents ranging from 4.5 to 
14.8 µg/100ml of milk (Table 2). A similar review of commercial foods in Germany reported milk 
(including breast milk, formula and milk from porridge) contributed significantly to iodine intake during 
the weaning period (34).  
Weaning infants fed home-prepared complementary foods may be at risk of iodine deficiency, 
because pediatric experts recommend not to add salt to complementary foods and not to feed cow’s 
milk to infants less than one year. These are the two most important sources of iodine in the diets of 
most industrialized countries, such as Switzerland, with iodized salt programs. This was supported by 
19 
 
the study of Swiss infants by Andersson et. al., where the median UIC in breast-fed weaning infants 
not receiving formula and/or complementary foods was significantly lower than infants receiving 
formula (70 vs. 109 µg/L) (23).  
 
Table 2: Comparison of labeled and measured iodine concentrations in different brands of formula 
milk and infant cereals (23) 
 Iodine concentration1 
Brand/ 
Product specification 
Labeled 
[μg/100 kcal]2 
Labeled 
[μg/100 ml] 
Measured 
[μg/100 ml]3 
Difference 
[%]4 
Infant formulas4 
Bimbosana  7.1 4.8 4.6 -3.3 
Bimbosan Bioa 7.7 5.2 4.5 -13.2 
Follow-on formulas5 
Adapta 2b 14.5 10 9.1 -8.8 
Coop Naturaplan Bio Galactina 2c 14.7 10 12.6 26.5 
HiPP Folgemilch 2d 14.3 11 11.6 5.8 
Holle Bio 2e 9.3 7 9.4 34.3 
Milupa Aptamil 2f 17.6 12 13.2 10.0 
Milupa Aptamil HA 2f 19.1 13 11.1 -14.6 
Milupa Milumil 2f 19.1 13 11.5 -11.5 
Nestlé Beba 2g 23.9 16 14.8 -7.6 
Nestlé Beba HA 2g 14.9 10 9.3 -6.9 
Soy-based formula 
Bimbosan Bisoja a 9.8 6.5 7.8 19.5 
Instant milk-cereals 
(to be prepared with water) 
Milupa Miluvid plusf 19.1 36 33.5 -6.9 
Nestlé Baby Cereals Vollkorn mit 
Früchteng 
8.5 18 18.3 1.7 
Nestlé Baby menu Milchgriessg 21.4 45 46.2 2.7 
Instant cereals 
(to be prepared with milk & water) 
Galactina  
Ceralino Milchzusatz Getreide & 
Ovomaltinec 
10.7 407 37.48 -6.5 
1 Refers to product as prepared ready-to-eat 
2 Calculated based on energy and iodine per 100 ml ready-to-eat product 
3 Measured by inductively coupled plasma mass spectrometry (ICP-MS) 
4 Percentage (%) of measured iodine concentrations compared to labeled iodine concentration 
based on μg/100 ml ready-to-drink product  
5 Cow milk-based, HA = partially hydrolyzed milk proteins 
6 Calculated based on energy and iodine per 100 g dry product, except for the Hipp ready-to-eat 
product 
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7 Standard portion as indicated on the package, varying from 175 to 200 g 
8 μg/100g instant powder. Only water used for the preparation 
a-g Products of 
a Bimbosan Ltd. (Welschenrohr, Switzerland) 
b Adapta (Lenzburg, Switzerland) 
c Coop (Basel, Switzerland) 
d HiPP GmbH (Sachseln, Switzerland) 
e Holle baby food GmbH (Riehen, Switzerland) 
f MILUPA SA (Domdidier, Switzerland) 
g Nestlé Suisse S.A. (Vevey, Switzerland) 
 
1.5. Recommendations 
• Because Swiss pregnant women overall are iodine sufficient, routine iodine supplementation 
during pregnancy is not needed for healthy women eating typical Swiss diets.  
• For those Swiss pregnant women who may have low iodine intakes, a prenatal supplement 
containing 150-200 µg iodine per day may be indicated.  
• Most prenatal supplements available in Switzerland do not contain iodine, and supplement 
manufacturers should be encouraged to include 150-200 µg iodine per day in their products.  
• Swiss pregnant women who are consuming iodized salt can also safely consume a prenatal 
iodine supplement containing 150-200 µg iodine per day.   
• Breastfed infants of iodine sufficient mothers obtain adequate iodine from breast milk and do 
not need supplemental sources of iodine. Once the infant has weaned from breast milk and is 
beginning to eat other foods, provision of iodine-fortified complementary foods, follow-on 
formula containing iodine and/or home-prepared foods containing iodized salt, may be 
important to meet their iodine requirements.  
• With the current fortification level of 20 ppm iodine in salt in Switzerland, iodine intakes are 
borderline sufficient in pregnant women and infants, but may be mildly deficient in non-
pregnant and lactating women. These data suggest it would be prudent to increase the iodine 
concentration in Swiss salt to 25 ppm.  
• Regular surveys on iodine status in pregnant women and infants in Switzerland are necessary 
to ensure adequacy in the face of changes in salt and food consumption practices. 
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2. The effects of iodine deficiency on cognition and 
learning in children 
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2.1. Summary  
The major impact of hypothyroidism due to iodine deficiency is impaired neurodevelopment, 
particularly early in life. In the fetal brain, inadequate thyroid hormone impairs myelination, cell 
migration, differentiation and maturation. Offspring of severely iodine deficient mothers are at high risk 
for cognitive disability, with cretinism being the most severe manifestation. It is less certain if mild-to-
moderate iodine deficiency during childhood impairs cognitive function and learning, but the two most 
recent randomized controlled trials (18,19) have shown benefits on children’s performance on 
cognitive tests. The positive results of these studies need to be replicated in other groups of mild-to-
moderately iodine deficient children before firm conclusions can be drawn. 
2.2. Introduction 
Iodine is an essential component of the hormones produced by the thyroid gland. Thyroid hormones, 
and therefore iodine, are essential for mammalian life. In 1907, David Marine, a U.S. physician, 
showed that endemic goiter (thyroid enlargement due to iodine deficiency) was caused by iodine 
deficiency (ID); five years later, goiter prophylaxis using iodized salt was introduced in Switzerland (1). 
Iodine (as iodide) is widely but unevenly distributed in the earth’s environment. In many regions, 
leaching from glaciations, flooding, and erosion have depleted surface soils of iodide. Crops grown in 
these soils will be low in iodine, and humans and animals consuming food grown in these soils 
become iodine deficient.  
Soils in the mountainous regions of Switzerland have very low iodine content due to extensive 
glaciation. As a consequence, these regions, up until the early 1900s, were afflicted by severe 
endemic goiter and cretinism. Introduction of iodized salt has eliminated these disorders in 
Switzerland. ID has multiple adverse effects on growth and development in animals and humans. 
These are collectively termed the iodine deficiency disorders, and are one of the most important and 
common human diseases (2,3). They result from inadequate thyroid hormone production due to lack 
of sufficient iodine.  
Worldwide, about 1.8 billion individuals still have insufficient iodine intakes, including nearly 1/3 of all 
school-age children (4). Iodine deficiency is not confined to developing countries, many industrialized 
countries are iodine deficient, including the United Kingdom and Australia, and it is estimated that ca. 
40% of school-aged children in Europe have low iodine intakes (4). Recommended iodine intakes in 
children, as well as older age groups, are shown in Table 3. 
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Table 3: Recommendations for iodine intake (µg/day) by age or population group 
Age or population 
groupa 
U.S. Institute of 
Medicine 
(ref.25) 
Age or population groupc World Health 
Organization 
(ref.5) 
Infants 0–12 months b 110-130 Children 0-5 years 90 
Children 1-8 years 90 Children 6-12 years 120 
Children 9-13 years 120   
Adults ≥14 years  150 Adults >12 years 150 
Pregnancy 220 Pregnancy 250 
Lactation  290 Lactation  250 
a Recommended Daily Allowance 
b Adequate Intake 
c Recommended Nutrient Intake. 
 
According to the World Health Organization (WHO), classification of iodine status in a population of 
school-age children should be based on the median UI concentration (UIC) (5). The concentration of 
iodine in urine is a good biomarker of recent iodine intake, because ca. 90% of dietary iodine is 
absorbed, and nearly all dietary iodine is ultimately excreted in the urine (3). As shown in Table 4, a 
UIC of 100-199 μg/L indicates optimal iodine nutrition in school-age children. In this review, mild iodine 
deficiency in a population of school-age children is defined as a median UIC of 50-99 μg/L, moderate 
iodine deficiency as a median UIC of 20-49 μg/L, and severe iodine deficiency as a median UIC of 
≤19 μg/L (5). 
 
Table 4: Epidemiological criteria from the World Health Organization (ref.5) for assessing iodine 
nutrition in a population based on median and/or range of urinary iodine concentrations. 
Median urinary 
iodine (μg/L) 
Iodine intake Iodine nutrition 
 School-aged children 
<20 Insufficient Severe iodine deficiency  
20-49 Insufficient Moderate iodine deficiency  
50-99 Insufficient Mild iodine deficiency  
100-199 Adequate Optimal 
200-299 More than adequate Risk of iodine-induced hyperthyroidism in 
susceptible groups 
>300 Excessive Risk of adverse health consequences (iodine-
induced hyperthyroidism, autoimmune thyroid 
disease) 
Pregnant women 
< 150 Insufficient 
150 – 249 Adequate 
250 – 499 More than adequate 
≥ 500 Excessivea  
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Median urinary 
iodine (μg/L) 
Iodine intake Iodine nutrition 
Lactating womenb 
< 100 Insufficient 
≥ 100 Adequate 
Children less than 2 years old 
< 100 Insufficient 
≥ 100 Adequate   
a The term “excessive” means in excess of the amount required to prevent and control iodine 
deficiency. 
b In lactating women, the figures for median urinary iodine are lower than the iodine requirements 
because of the iodine excreted in breast milk. 
 
2.3. Iodine deficiency, hypothyroidism and the developing brain 
In areas where dietary iodine intake is adequate, the healthy thyroid gland traps 60-80 μg of 
iodine/day to balance losses and maintain thyroid hormone synthesis (3). Below this level of thyroid 
uptake, the iodine content of the gland is depleted, and many individuals develop goiter. Goiter, an 
enlargement of the thyroid gland visible as an abnormal swelling at the base of the neck, develops in 
iodine deficient individuals because the thyroid increases its size in an attempt to filter more iodine 
from the bloodstream. In chronic iodine deficiency, thyroid hormone synthesis is limited by lack of 
iodine. This leads to low concentrations of thyroid hormone in the blood, a condition termed 
hypothyroidism. This can damage the developing brain (2,3). 
Thyroid hormone receptors are present throughout the central nervous system and thyroid hormone 
has a myriad of important effects in the developing brain that include accelerated myelination and 
improved cell migration, differentiation and maturation (6). Hypothyroidism due to in utero iodine 
deficiency irreversibly impairs neural development in the hippocampus; the hippocampus is particularly 
important in learning in that it integrates spatial and contextual information (7). The detrimental effects 
of hypothyroidism on the developing brain depend on its timing, magnitude and duration. Early in the 
life cycle the brain is most vulnerable, but hypothyroidism has adverse effects on cognition even in 
adulthood (8).  
Hypothyroidism due to severe iodine deficiency in utero can result in cretinism (2,3). There are two 
classic forms of cretinism − neurological and myxedematous (see Chapter 1 of this report). In areas of 
severe iodine deficiency, iodine treatment prevents cretinism and, in noncretinous offspring, improves 
psychomotor and developmental scores (3). Cretinism is no longer common due to the rapid 
expansion of programs of salt iodization worldwide, although it may still occur in remote areas. 
Therefore, the remainder of this paper will focus on the potential adverse effects of more mild iodine 
deficiency. 
The cognitive deficits associated with iodine deficiency may not be limited to remote, severely iodine 
deficient areas. Experts have argued that even mild-to-moderate iodine deficiency in pregnancy, still 
present in many countries around the world, may affect cognitive function of the offspring. However, 
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this remains uncertain (12) (see Chapter 1 of this report). No well-controlled prospective studies have 
evaluated the effects of iodine repletion in mild-to-moderately deficient pregnant women on child 
cognitive or motor development. Because of this, the potential adverse effects of mild-to-moderate 
iodine deficiency during pregnancy on later childhood cognition and learning remain unclear. 
2.4. Cross sectional studies in childhood 
There have been many cross-sectional studies comparing cognition and/or motor function in children 
from chronically iodine deficient and iodine sufficient areas, including children from Asian and 
European backgrounds (13). These cross-sectional studies, with few exceptions, report impaired 
intellectual function and motor skills in children from iodine deficient areas. However, observational 
studies are often confounded by other factors that affect child development. Also, these studies could 
not distinguish between the persistent effects of in utero iodine deficiency and the effects of current 
iodine status. 
2.5. Randomized controlled trials 
Several early randomized, controlled trials in school-aged children tried to measure the effect of 
iodized oil on cognition (14-17) but methodological problems limit their interpretation.  In a well-
designed, placebo controlled, double-blind 6 month intervention trial, moderately iodine deficient 10-
12 y-old children (n=310) in Albania (18) were randomized to receive either 400 mg of iodine as oral 
iodized oil or placebo. Treatment with iodine markedly improved iodine and thyroid status: at 24 wk, 
median UIC in the treated group was 172 µg/L and mean circulating T4 increased ≈40%. Compared to 
placebo, iodine treatment significantly improved information processing, fine motor skills, and visual 
problem solving (18).  
Another carefully conducted, randomized controlled trial in 10–13 y children (n=184) in New Zealand 
(19) gave a daily tablet containing 150 µg iodine as KI or placebo for 28 wk. Cognitive performance 
was assessed through 4 subtests from the Wechsler Intelligence Scale for Children after 28 wk. 
Thyroid hormone concentrations were in the normal range at baseline for all children. Despite this, 
iodine improved scores on 2 of the cognitive tests: picture concepts (P = 0.023) and matrix reasoning 
(P = 0.040). Overall cognitive score of the iodine group was 0.19 SDs higher than that of the placebo 
group (P = 0.011) (19).  
In these two studies (18,19), increasing iodine intakes over several months improved cognition in older 
children who presumably grew up under conditions of iodine deficiency. This short-term beneficial 
effect may have been due to improvements in myelination of central nervous system mediated by an 
increased supply of thyroid hormone (20). Myelinization continues throughout childhood particularly in 
the frontal cortex, the brain area responsible for higher-order cognition and fluid intelligence. 
Alternatively, better thyroid function could improve cognition by effects on neurotransmitters and/or 
glucose metabolism (21).  
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2.6. Meta-analyses  
Two meta-analyses have been done to look at the effects of iodine deficiency on the Intelligence 
Quotient (IQ). In the first, the authors looked at the effect of iodine deficiency on mental development 
in both adults and children (22). They pooled data from 21 observational and experimental studies 
done in areas of moderate-to-severe iodine deficiency. The IQs of non-ID groups were on average 
13.5 IQ points higher than those of the iodine-deficient groups. In a second meta-analysis by Qian et 
al. (23) that pooled data from studies in Chinese children, there was an increase of ≈12 IQ points for 
children born more than 3.5 years after iodine prophylaxis was introduced.  Based on the close 
agreement of the overall effect in these two large meta-analyses, it appears moderate-to-severe iodine 
deficiency reduces the IQ by 12-13 points (22,23). 
2.7. Recommendations 
• School-age children (6-12 y-olds) have a daily iodine requirement of 120 µg/day 
• The main exposure biomarker used to assess iodine intakes in schoolchildren is the median 
urinary iodine concentration (UIC), and a median UIC of 100-199 μg/L indicates optimal iodine 
nutrition in a population of school-age children. Chapter 3 of this report includes a discussion 
of the iodine status in school-age children in Switzerland.  
• The clear benefits of iodine repletion in school-age children demonstrated in the New Zealand 
study (19) are particularly relevant for the European/Swiss setting, in that these children were 
only mildly deficient and came from middle-class backgrounds and school environments 
similar to that of many European children.  
• Until more data become available, the prudent course is to ensure all school-aged children 
have ample iodine intakes and avoid even mild degrees of iodine deficiency.  
• Switzerland is fortunate in this regard, because the long-running Swiss iodized salt program, a 
model for most other countries, has provided adequate iodine to school children in Switzerland 
for decades (see Chapter 3 of this report). But it is critical not to become complacent.  
• Children are vulnerable to even short-term lapses in salt iodization programs (3), and the 
dietary iodine supply in Switzerland is influenced by many hidden factors (see Chapter 4 of 
this report).  
• Regular monitoring of iodine status in children, with appropriate adjustments to the iodine 
content in salt if needed, will ensure this ancient scourge remains eliminated in Switzerland. 
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3.1. Summary 
Historically, Switzerland has proceeded cautiously with iodine fortification of salt, raising the iodine 
content of salt in four steps over a period of 90 years, from 3.75 ppm to the current level of 20 ppm 
iodide. The goiter rate in school-age children is now below 5% and no new cretins have been born 
since 1930. In the last two national surveys, in 2004 and 2009, the median UIC in school-age children 
and pregnant women indicated sufficient iodine intake. However, iodine intakes fell in these groups 
between 2004 and 2009. Thus, although Switzerland can now be considered an iodine sufficient 
country, free of goiter and cretins, iodine intakes appear to be decreasing, and are currently at the 
lower end of the recommended range in pregnant women and children. In addition, infants, lactating 
women and women of reproductive age have borderline low iodine intakes. Thus, these monitoring 
data suggest a modest increase in the iodine content of Swiss salt is needed in order to ensure iodine 
sufficiency in all population groups.  
3.2. Historic epidemiology of iodine status 
3.2.1 First epidemiologic surveys 
For centuries, visitors to Switzerland were struck by the numerous inhabitants afflicted with goiter, 
sometimes combined with short stature, deaf-mutism and mental retardation. From the early 19th 
century onward the search for an etiology and treatment of this condition produced an appreciable 
scientific body of literature, which Merke, a surgeon from Basel, summarized in a superb volume in 
1971 (1). In 1990, we updated Merke’s Swiss data (2) and this review marks 80 years of uninterrupted 
use of iodized salt in Switzerland.  
The frequent depiction of goiter and cretinism in older artworks in Europe indicates that the population 
was frequently affected by iodine deficiency. Rates of goiter in older records provide an estimate of the 
extent of iodine deficiency. Results of military drafts proved a rich source of such data. Not satisfied by 
the poor yields of the draft for the French army in the Département du Simplon (today the Swiss 
Canton du Valais), Napoleon ordered a census of cretins in 1810. It reported the high number of 
4’000 cretins among a population of 70’000 (1). 
Heinrich Bircher (3) compiled in an exhaustive monograph the tables and maps of goiter prevalence at 
recruitment in the years 1875 to 1880 for every single town and village in Switzerland, together with 
the prevalence of deaf-mutism and cretinism in selected areas. He concluded that goiter prevalence 
varied enormously from one village to another, even within the same county. Since military service is 
compulsory in Switzerland, all men must pass through a military medical board at age 19. In the years 
1886 to 1891, 8 to 11% were found unfit for service due to a large goiter, with smaller goiters not being 
a reason for exemption (4). Theodor Kocher, the famous Bernese surgeon and Nobel Prize winner, 
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surveyed in 1883/84 all 76’606 schoolchildren of the Canton of Berne (5) and found that, depending 
on the location, the prevalence of goiter varied between 20 and 100%.  
In a remarkable study, Als analyzed historical paintings and photographs of members of the 
aristocratic citizen’s community of Berne, dating from the 16th to the 19th century (6). In the 
2’356 individuals whose neck was visible in a portrait, she found evidence for goiter in 44% of women 
and 24% of men; the prevalence remaining stable over the four centuries covered by the study (6). 
Thus, although early studies on the epidemiology of iodine deficiency were not up to modern 
standards, the presence of historical goiter and cretinism in endemic proportion in Switzerland were 
documented beyond any doubt. 
3.2.2 1922-23: The turning point 
Bayard, a general practitioner in the valley of Zermatt, was convinced of the iodine deficiency theory of 
the etiology of goiter and believed side-effects of iodine treatment were due to inappropriately high 
dosages. In a dose-response study he personally provided 5 large families including their baker and 
their cattle with salt containing 3, 6, 9, 12 or 15 ppm of iodide. Noting that their goiters shrunk, he then 
supplied two entire villages with salt containing the lowest dose, after having established goiter size 
and prevalence among the 1’200 inhabitants. Then, the dose was raised at 6-month intervals in one of 
the two villages to 7.5 and then to 15 ppm of iodide. Bayard found that the lowest dose, which 
presumably provided roughly an additional 40 μg iodine per day, was capable of shrinking some, but 
not all goiters. The next higher dose (15 mg/kg) was more effective and was well- tolerated without 
adverse reactions (7, 8). 
Eggenberger, chief surgeon at the hospital in Herisau, agreed with Bayard’s dose recommendations 
and decided it was time to act. In 1922, he started a campaign of evening lectures in every single 
community of his small Canton of Appenzell Ausserrhoden and then collected 3’480 signatures for a 
petition to the government of the canton. Within one week the government approved a trial of universal 
salt iodization (9-11)! Eggenberger went to work immediately. With the help of family members he 
personally added 10 mg KI per kg salt (7.5 ppm iodide) using a simple hand-and-shovel method for 
mixing.  
Within one year, in 1923, existing goiters had shrunk in 66% of the schoolchildren whose families used 
iodized salt on a regular basis, compared with only 28% in those families who did not. Estimated mean 
thyroid gland weight in children entering primary school diminished from 21 to 13 g, and the presence 
of a palpable thyroid gland in newborns, originally affecting 50% of newborns, had entirely 
disappeared (11-13). In November 1922, the United Swiss Rhine Salt Works, the exclusive supplier to 
24 of 25 cantons, took up production of salt containing 5 mg KI (3.75 ppm iodide) per kg.  
3.2.3 The Swiss Goiter Commission and dose problems 
In 1922, the Swiss Federal Office of Public Health installed the Swiss Goiter Commission, which 
included most persons engaged in goiter research in Switzerland. On June 24, 1922 the Commission 
recommended to the 25 Cantons to take up the sale of salt containing 2.5 to 5 mg KI (1.9-3.75 ppm 
iodide) per kg on a voluntary basis, with non-iodized salt remaining available (14, 15). Eggenberger 
correctly predicted that this dose would turn out to be too low to eradicate goiter completely, but it was 
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a compromise to which even the opponents of iodized salt could agree. The Swiss Goiter Commission 
convened about once a year, it organized two big international goiter conferences in 1927 and 1933 in 
Berne and it monitored progress of the USI program.  
Some members of the Commission were adamantly opposed to universal salt iodization (USI) and 
blocked its introduction in some cantons, as well as the dose increase in some other cantons. Some 
cantons complied reluctantly, and not before 1955 all cantons had agreed. Side-effects of 
hyperthyroidism (iodine-induced hyperthyroidism) were closely monitored, but could not be observed 
in epidemiological studies. Even though urinary iodine excretion in the 1930s showed persisting 
moderate iodine deficiency (Table 5), the Commission was unable to agree on higher salt iodine 
content in Switzerland and the Swiss Goiter Commission thereupon stopped its activities. Finally, in 
1962, the Swiss Rhine Salt Works, frustrated with having to produce salt with different specifications 
for every canton, decided on its own to increase the iodide content of salt from 3.75 to 7.5 ppm. 
 
Table 5: Overview of field studies in Switzerland from 1923 to 2009. 
Year Iodine in 
salt (mg/kg) 
Iodine in 
urine (μg/L) 
Population and sample size Reference 
1923 None 18 23 inhabitants of 2 goitrous villages (35, 36) 
1939 3.75 36 Goitrous and non goitrous adults Canton 
Berne 
(37) 
1975 7.5 <1001 Patients hospitalized in 1975 (16) 
1979 7.5 76-93 Healthy adults (17) 
1981-
1988 
15 127-160 112 outpatients and 245 school children (2) 
1984 15 97 112 healthy adults  (52) 
1994 15 1181 214 school children Canton Solothurn (38) 
1997 15 96 243 school children from Zurich area and 
Engadine valley 
(39) 
1998 15 94 412 subjects in Bern region (infants, 
children, adolescents, adults and seniors) 
(53) 
1999 15-20 115 National sample of 600 school children (19) 
2004 20 141 National sample of 386 school children (20) 
2009 20 120 National sample of 916 school children (21) 
1 μg/g creatinine 
 
In the 1970s, available data suggested that this dose was still too low (16, 17). In 1980, the iodine 
content in salt was raised to 15 ppm iodide, without causing protests. In 1988, 92% of retail salt and 
76% of all salt for human consumption (including food industry) was iodized, even though noniodized 
salt still remained available. Table 5 shows the effects of increasing the dose of iodine in salt on 
urinary iodine content. Since 1999, the median urinary iodine concentration (UIC) has remained above 
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the limit of 100 μg/L set by the WHO (18). And since 1999 the Swiss iodine status is reassessed by a 
nationally-representative survey performed at 5-year intervals according to the WHO standards. 
In 1977 the Fluorine Commission of the Swiss Academy of the Medical Sciences (that had existed 
since 1950) was additionally charged to address iodine nutrition in Switzerland and the iodized salt 
program. Renamed the Fluorine-Iodine Commission, it currently supervises the salt iodization 
program, reports to the Federal Office of Health and recommends adjustments to the salt iodine 
content when necessary. 
3.3. Current epidemiology of iodine status  
3.3.1 School children 
Three national studies conducted in 1999, 2004 and 2009 evaluated the iodine status in 6 to 13 year 
old school children (19-21). The iodine intake is now overall adequate with a median UIC of 120 µg/L 
in children (21). Table 4 in Chapter 2 shows the median UIC criteria for defining iodine status in 
different age groups and populations. The three nationwide studies demonstrate a stable optimal 
iodine status over the last 10 years (Figure 2). Adequately iodized salt is consumed by 80% of 
children and the measured median iodine content in collected salt samples (iodized) is 19.8 mg/kg 
(range: 15.1-33.0) (Table 6). In the 1999 study the prevalence of goiter was determined by measuring 
thyroid volume by ultrasound (19, 22). The goiter prevalence was 3.9%, confirming that the goiter 
prevalence is now below the WHO threshold of 5% (18) and hence no longer a public health concern 
in Swiss children. 
 
Figure 2: Median (25th, 75th percentiles) urinary iodine concentration in Swiss 6-12 y old children in 
1999, 2004 and 20091,2. 
1 The shaded grey box show the range of median UIC that indicates sufficient iodine status defined 
by WHO (18). 
2 Adapted from (19-21).  
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Table 6: Iodized salt use in Swiss school children and pregnant women during the last ten years. 
Year n Iodized salt (%) Iodine concentration1 (mg/kg) Reference 
School children2 
19993 105 87 13.7 ± 1.94 (19) 
2004 85 85 18.3 ± 3.04, 5 (20) 
2009 266 80 19.8 (15.1-33.0)6 (21) 
Pregnant women7 
2009 648 74  (21) 
1 Iodine concentrations in salt samples with iodine concentrations greater than 10 ppm (1999 and 
2004) and 15 ppm (2009) 
2 Iodine concentrations measured in collected salt samples 
3 Zürich metropolitan area 
4 Mean ± SD 
5 Significant increase compared to 1999 (P < 0.01) 
6 Median (range) 
7 Questionnaire asking about the use of iodized salt 
 
3.3.2 Pregnant women 
The dietary iodine requirements increase by more than 50% during pregnancy (see Chapter 1 of this 
report) (18, 23). The iodine status in pregnant women was evaluated in the three national studies 
conducted in 1999, 2004 and 2009 (Figure 3) (19-21). The median UIC in the most recent study was 
162 µg/L (95% CI 144-177) and the iodine intake is now adequate also in pregnant women (21). The 
percentage of pregnant women who reported using iodized salt was 74% (Table 6). Seventy-nine 
percent of the women were taking nutritional supplements, but only 15% were taking supplements 
containing iodine (Table 7). The use of iodine containing supplements during pregnancy has remained 
stable over the last 10 years and does not explain the intermediate increase in median UIC in 2004 
(Figure 3). 
 
Table 7: Prenatal supplement use with and without iodine in Swiss pregnant women during the last 
ten years. 
Year  Prenatal supplement 
use (%) 
Prenatal supplement use 
with iodine (%) 
Reference 
1999  70 13 (19) 
2004  62 9 (20) 
2009  79 15 (21) 
 
Thyroid volume and goiter prevalence have not been measured in pregnant women. However, 
unpublished thyroid function data from the 2009 study show no cases of hypo- or hyperthyroidism 
using the normal ranges of 0.2-4.0 mU/L for thyrotropin (TSH) and 100-200 nmol/L for thyroxin (T4) 
levels (24). The median TSH and T4 concentrations were 0.63 mU/L (range: 0.3-2.59) and 107 nmol/L 
(range: 21.2-199), respectively. 
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Figure 3: Median (25th, 75th percentiles) urinary iodine concentration in Swiss pregnant women in 
1999, 2004 and 20091,2. 
1 The shaded grey box show the range of median UIC that indicates sufficient iodine status defined 
by WHO (18). 
2 Adapted from (19-21). 
 
Thyroglobulin (Tg) is another sensitive marker of iodine status and thyroid function as elevated values 
reflect increased TSH stimulation due to iodine deficiency. WHO recommends Tg as a complementary 
marker to UIC to monitor iodine nutrition in children (18). Tg may be useful also in adults (25) and in 
pregnant women (26). The measurement of Tg in dried blood spots (DBS) has been developed for 
large population studies and is simple to use in the surveillance of iodine status in routine obstetric 
check-ups. We measured DBS-Tg in pregnant women in the 2009 study and the median Tg 
concentration was 8.0 ng/mL (range: 0.0-121). Reference ranges are available for school children 
(27), but not yet for adults or pregnant women. However, studies in iodine replete and iodine deficient 
populations of pregnant women suggest that Tg remains at pre-pregnancy concentration in iodine 
sufficiency, but increases in iodine deficiency (28-30). Using the reference ranges for children (3-
40 ng/L), only 2.3% of all women had Tg levels above 40 ng/L. This agrees with the assumption that 
no more than 5% of subjects should have elevated Tg levels in an iodine sufficient population and 
confirms appropriate thyroid function in Swiss pregnant women. 
3.3.3 Women of reproductive age 
A recent study of female students (n=683) at the ETH Zürich reports a median UIC of 79 µg/L (range 
3-621), indicating borderline low iodine intakes using present WHO criteria for UIC to assess iodine 
status in adults (Figure 4) (31). However, we have recently questioned the validity of the present 
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WHO threshold of 100 µg/L for median UIC in adults (31). This cut-off was developed for children, but 
is likely too high for adults and should probably rather be approximately 60-70 µg/L. We suggest 
iodine status and the prevalence of inadequate iodine intake should be evaluated in this age group 
based on the Estimated Average Requirement (EAR) cut-off point method. Using this approach, as 
described in reference 31, only 7% of the young women in the ETH study have inadequate iodine 
intakes. 
 
Figure 4: Present iodine status in the Swiss population1,2. Data presented as medians (25th, 75th 
percentiles). 
1 The shaded grey boxes show the ranges of median UIC that indicate sufficient iodine status 
defined by WHO (18). 
2 Adapted from (21, 31) 
 
3.3.4 Lactating women 
Lactating women have high iodine requirements as extra iodine is needed due to its excretion into the 
breast milk (23). The iodine status was measured for the first time in a national study of 507 mothers 
of weaning infants in 2009 (21). The median UIC of the mothers was 75 µg/L (95% CI 69-81) and the 
breast milk iodine concentrations (BMIC) in the women who were still breastfeeding was 49 µg/kg. 
Eighty four percent used iodized salt, but only 3% used iodine containing supplements. The median 
UIC of lactating women did not significantly differ from non-lactating mothers (67 µg/L, n=196 vs. 
81 µg/L, n=311) and agrees well with the UIC reported in women of reproductive age. The WHO 
38 
 
threshold for defining iodine sufficiency in lactating women is 100 µg/L, the same as that for non-
pregnant adult women (32). The iodine excreted in breast milk accounts for the difference between the 
higher dietary iodine requirements and the iodine excreted in the urine. Considering the discussion of 
UIC thresholds above, it is unclear if a median UIC of 75 µg/L indicates iodine deficiency during 
lactation.  
3.3.5 Newborns and infants 
The iodine status of newborns and weaning infants was evaluated in two studies, one by Dorey and 
Zimmermann in 2005 (33) and another by Andersson et al. in 2009 (21). UIC was measured in three 
separate national samples of infants during the first week of life, at 6 months and 12 months of age. 
The median UIC was 91 µg/L (95% CI 82-99) in newborns, 91 µg/L (95% CI 79-103) in 6 months olds 
and 103 µg/L (95% CI 92-116) in 12 months old children (Figure 4).  
The study showed that breast-fed weaning infants may be at risk of inadequate iodine intakes due to 
the rather low BMIC. Median UICs in breast-fed weaning infants (82 µg/L) was lower than in non-
breast-fed infants (105 µg/L) (p < 0.001). Iodine containing follow-on infant formula milks may be a 
complementary dietary iodine sources during the weaning period. About 60% of all infants were 
occasionally or regularly receiving one or more meals of infant formula milk and their median UIC was 
higher than those not receiving iodine containing infant formula milk (109 µg/L, n=304 vs. 73 µg/L, 
n=203) (p<0.001). However, the results do not suggest that iodine fortified infant formula milk is 
necessary to achieve optimal iodine nutrition in weaning infants. The median UIC in weaned infants 
fed homemade and/or complementary foods in glass jars was 89 µg/L in those not receiving breast 
milk or infant formula milk, but their UIC was not significantly different from to those who got breast 
milk and infant formula milk (109 µg/L, n=304). Breast milk is the most important iodine source during 
infancy and lactating women should be advised to consume iodized salt and choose foods produced 
with iodized salt.  Breastfed infants of iodine sufficient mothers will obtain adequate iodine from breast 
milk and do not need supplemental sources of iodine.  
The median UICs in newborns and 6 month old infants are just below the WHO UIC cut-off as shown 
in Figure 3; however, the study results are difficult to interpret. The iodine requirements in infants are 
poorly defined and the UIC to define sufficiency is uncertain. The current recommended dietary iodine 
intake for 0-6 month old infants (110 µg/day) is an adequate intake (AI) because there is insufficient 
data to establish an EAR for this age group. This AI is based on the iodine intake in breast fed infants 
from BMIC measured in U.S women during a period when overall iodine intakes in the U.S. population 
were excessive and the AI may be too high. The WHO recommends iodine intakes at this age to be 
90 µg/day, slightly lower. We are currently planning a metabolic balance study in 2-3 month old infants 
to define the EAR and thresholds for UIC in this age group.  
The newborn screening program routinely measures TSH in newborns on days 3 and 4 after birth. 
Zimmermann et al. (20) evaluated the neonatal screening program for Eastern Switzerland in 2005 
and showed that the prevalence of newborn TSH <5 mU/L decreased from 2.9 % in 1992-1998 
(before the increase in salt iodine concentration from 15 to 20 mg/kg) to 1.7% in 1999-2004 (after the 
increase) (p < 0.0001). These data confirm satisfactory thyroid function in young infants.  
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3.4. The effects of increasing iodine intakes in populations and iodine excess 
European (40) and USA (41) expert committees have recommended tolerable upper intake levels for 
iodine (Table 8), but caution that individuals with chronic iodine deficiency may respond adversely to 
intakes lower than these. In monitoring populations consuming iodized salt, the World Health 
Organization/International Council for Control of Iodine Deficiency Disorders (WHO/ICCIDD) 
recommendations for the median UIC that indicates more-than adequate and excess iodine intake in 
school age children are 200-299 μg/L and >300 μg/L, and the median UIC that indicates excess iodine 
intake in pregnant women is >500 μg/L (18). 
 
Table 8: Tolerable upper intake level for iodine (μg/day) 
Age group European Commission/Scientific 
Committee on Food (40) 
US Institute of Medicine (41) 
1–3 y 200 200 
4–6 y (4-8 y)1 250 300 
7–10 y (9-13 y)1 300 600 
11–14 y  450 … 
15–17 y (14-18y)1 500 900 
Adult 600 1100 
Pregnant women 600 1100 
Age categories in parenthesis are for the tolerable upper level defined by US Institute of Medicine (41). 
 
In areas of iodine sufficiency, such as Switzerland, most healthy adults are remarkably tolerant to 
iodine intakes up to 1 mg per day, as the thyroid is able to adjust to a wide range of intakes to regulate 
the synthesis and release of thyroid hormones (42). However, doses of iodine in the 200-
500 microgram range may cause hyper- or hypothyroidism in those with past or present thyroid 
abnormalities. Signs and symptoms of iodine-induced hyperthyroidism include weight loss, rapid and 
irregular heartbeat, difficulty sleeping, fine tremor and anxiety. This occurs because, in a damaged 
thyroid gland, the normal down-regulation of iodine transport into the gland may not occur. Thus, even 
in so-called iodine sufficient populations, because some individuals will have past or present thyroid 
disorders, it is to be expected that changes in population iodine intake will affect the pattern of thyroid 
diseases.  
Epidemiological studies on the relationship between iodine intake and the thyroid diseases have 
reported that populations with long-standing mild to moderate iodine deficiency demonstrate a high 
prevalence of thyroid hyperfunction but a low prevalence of thyroid hypofunction, while populations in 
areas of high iodine intake show the opposite pattern (43, 44). In mildly iodine deficient areas, there is 
an increase in thyroid multinodularity in females with advancing age that results in more cases of toxic 
nodular goiter (45, 46). Thus, like diffuse goiter, thyroid hyperfunction is part of the spectrum of 
disorders caused by mild-to-moderate iodine deficiency.  
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The overall incidence of differentiated thyroid carcinoma in populations does not appear to be 
influenced by iodine intake. Some studies have suggested the distribution of the subtypes of thyroid 
carcinoma is related to iodine intake; in areas of higher iodine intake, there appear to be fewer of the 
more aggressive follicular and anaplastic carcinomas, but more papillary carcinomas (47). When 
iodine prophylaxis is introduced in populations, this shift toward less malignant types of thyroid cancer, 
as well as a lower radioactive iodine dose to the thyroid in case of nuclear fallout, are benefits of the 
correction of mild-to-moderate iodine deficiency. 
Increasing iodine intakes in iodine-deficient populations is typically accompanied by a rise in the 
incidence of hyperthyroidism. In Switzerland in 1980, when the population was mildly deficient and the 
iodine content of salt was raised from 7.5 to 15 ppm, the UIC increased from ≈ 80 to 150 µg per gr 
creatinine. In the first 2 years after this increase, the incidence of toxic nodular goiter rose by 12%, but 
gradually regressed to a stable level at only 25% of the initial incidence (48). The magnitude of the 
increase in iodine-induced hyperthyroidism (IIH) in populations depends on the amount of iodine 
administered and the severity of the pre-existing iodine deficiency. The increase in the incidence of IIH 
after a properly-monitored introduction of iodine is transient, because the resulting iodine-sufficiency in 
the population reduces the future risk of developing of autonomous thyroid nodules.  
Denmark has documented the pattern of thyroid disease after careful introduction of iodized salt (49, 
50). New cases of overt hypothyroidism were identified in two areas of Denmark with previous 
moderate and mild iodine deficiency, respectively (Aalborg, median UIC=45 µg/L; and Copenhagen, 
median UIC=61 µg/L) before and for the first 7 yr after introduction of a national program of salt 
iodization. The overall incidence rate of hypothyroidism modestly increased during the study period, 
from 38.3 to 47.2/100,000, with most cases in young and middle-aged adults. Similarly, new cases of 
overt hyperthyroidism in these two areas of Denmark before and for the first 6 yr after iodine 
fortification were identified. The overall incidence rate of hyperthyroidism increased from 102.8 to 
138.7/100,000, with the increase occurring in both sexes and in all age groups. However, these data 
should be interpreted with some caution because the incidence rates for hypo- and hyperthyroidism in 
Denmark were already increasing before the introduction of iodized salt. 
The current median UICs in school children and pregnant women in Switzerland are 120 µg/L and 
162 µg/L, and the percentage of school-aged children above the UL of 300 µg/day was <1% in 2009. 
Thus, the current iodized salt program is not placing the Swiss population at risk for iodine excess. If 
the iodine content in Swiss salt were to increase ca. 20% (i.e. if the iodine level is increased from 20 to 
25 ppm in 2013), there would still be very low risk of iodine excess. WHO/ICCIDD currently 
recommend to set salt iodization levels in national programs in the range of 20 to 40 ppm (18), and the 
Swiss fortification level is at the lower end of this recommended range.   
More prospective data on the epidemiology of thyroid disorders caused by changes in iodine intake in 
other countries would be valuable. But it appears achieving optimal iodine intakes (in the range of 150-
250 µg/d for adults) can minimize the amount of thyroid dysfunction in populations (51). Iodine 
prophylaxis with periodic monitoring is an extremely cost effective approach to help control thyroid 
disorders, compared to clinical diagnosis and treatment. If programs of iodine prophylaxis are carefully 
monitored for both iodine deficiency and excess, the relatively small risks of iodine excess are far 
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outweighed by the substantial risks of iodine deficiency — pregnancy loss, goiter, and mental 
retardation. 
3.5. Conclusions 
• In the last two national surveys, in 2004 and 2009, the median UIC in school-age children and 
pregnant women indicated sufficient iodine intake. However, iodine intakes fell in these groups 
between 2004 and 2009, and are currently at the lower end of the recommended range in 
pregnant women and children.  
• Infants, lactating women and women of reproductive age have borderline low iodine intakes.  
• The current iodized salt program is not placing the Swiss population at risk for iodine excess. 
• The monitoring data suggest a modest increase in the iodine content of Swiss salt is needed 
in order to ensure iodine sufficiency in all population groups. Moreover, a modest increase in 
the iodine content of Swiss salt will not place the Swiss population at risk for iodine excess. 
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4.1. Summary 
In Switzerland, the Federal Office of Public Health (BAG) measures the content of iodine in food 
groups to identify and quantify major sources of dietary iodine in the population. Nearly all foods, with 
the exception of marine fish, contain very low amounts of native iodine. Iodized salt, used as an 
ingredient in food production, is the main source of iodine in the Swiss diet. Good sources of dietary 
iodine are marine fish, bread, eggs, and dairy products. The mean iodine concentration in other 
foodstuffs, such as meat, vegetables and fruits, is extremely low. Overall, bread and dairy products are 
the main contributors of iodine intake. The high iodine content of milk is adventitious, originates largely 
from cattle feed and has been shown to vary strongly depending on season and use of iodine 
containing supplements. Cheese is an important nutritional source of iodine, yet most cheese 
producers have discontinued the use of iodized salt due to changes in labeling requirements for 
iodized salt and the inability to export products containing iodized salt. Iodized salt consumed from 
home-cooked food is only a small proportion of the total iodine intake since most of the salt 
consumption arises from consumption of processed foods. Therefore, consideration of any changes to 
the iodine salt content should be made with regard to the food industry rather than private households. 
A Swiss adult following the dietary recommendations of the Swiss Society for Nutrition and the Federal 
Office of Public Health will have an estimated mean iodine intake of ca.145 µg/day, close to the adult 
mean requirement of 150 µg/day recommended by the World Health Organization. However, people 
following a strict vegan diet without milk or eggs may be at risk of iodine deficiency, particularly if they 
do not use iodized salt. Nutritional habits, food formulation and production procedures are constantly 
changing, and since all of these factors can influence iodine intakes, regular monitoring of iodine 
nutrition in Switzerland remains important.  
4.2. Introduction 
Despite the serious effects of iodine deficiency in populations, few people are aware of the importance 
of maintaining sufficient iodine levels in their diet. Iodine in food and drinking water are virtually the 
only natural source of iodine for humans. In spite of this, direct measurements of food iodine content 
are rare in most countries. This is in part due to the fact that iodine intake can be indirectly assessed 
by an exposure biomarker, the measurement of urinary iodine excretion (1, 2). Another reason is that 
the determination of iodine in foods is an analytic challenge, especially at the relatively low 
concentrations that occur naturally.  
However, detailed knowledge of the iodine content of foods nutrition is valuable in guiding nutrition 
policies to ensure adequate, but not excessive, iodine intakes in populations. In many industrialized 
countries, including Europe, iodine levels in the general population may be decreasing. Of the 
40 European countries surveyed in a 2007 report, 19 have adequate iodine nutrition, 12 mild 
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deficiency, one moderate deficiency and there is insufficient data for eight countries (3). Ten years 
ago, the Federal Office of Public Health (BAG) initiated a study on iodine in food groups to identify and 
quantify major sources of dietary iodine (4). Chemical analysis of iodine was carried out on foods 
selected according to consumption frequency data of vital foodstuffs, including studies on cheese and 
milk (5, 6). This report is based on previous Swiss studies and new or unpublished data on foods. 
Special emphasis is thereby given to milk, cheese and bread. 
4.3. Analysis of iodine in food 
The peculiar chemistry of iodine turns the determination of iodine in foods into one of the most 
demanding tasks in modern nutrient analysis. Most of the popular procedures for iodine determination 
are based on the Sandell-Kolthoff reaction, which makes use of the catalytic effect of iodine in the 
oxidation-reduction process between cerium (IV) and arsenic (III). However, for samples other than 
urine this method is difficult to operate. Significant advances in the analysis of foods can be attributed 
to the advent of inductively coupled plasma mass spectrometry (ICP-MS). Unfortunately, the volatility 
of iodine and matrix effects of food samples hampers its quantification. To solve these problems, we 
developed a method based on isotope dilution analysis (7). In essence, the amount of iodine is 
calculated from the change of the isotope ratio induced by the addition of the long-lived radio isotope 
iodine-129, which is chemically the same substance. Thus, the susceptibility to errors is the same for 
both isotopes and the ratio remains unchanged. Unless stated otherwise, the iodine data given in this 
report were measured by isotope dilution ICP-MS at the BAG.  
4.4. Iodine in the Environment 
Iodine is one of the most abundant micronutrients in seawater, with concentrations of 50 to 60 µg/l. 
Iodine accumulates in seaweeds and algae, fish and shellfish (8). On land, the iodine content of water 
depends on the geochemical environment and leaching from the rock or soil into water sources. 
Subsequently, it is taken up by plants (to differing extents) and enters the food chain (9). Inland, 
mountainous regions, such as regions of Switzerland, are known to be typically iodine poor. Bee 
honey is regarded as an environmental indicator of trace element occurrence. Analysis of Swiss honey 
samples (10) showed low iodine contents, an indication that the soil is iodine poor (Table 9). In 
Switzerland, drinking water is a negligible source of iodine (11-13).  
 
Table 9: Iodine concentration in basic food groups from the Swiss market.  
Food Group  Iodine in dry food (µg/kg)  fresh food (µg/kg) 
 n Mean ± SD Median P95 %1   Mean Median 
         
Cereals and grains         
Bread  1999 -2001 76 400 211 396 823  309 313 
Bread  2011/12 64 482 73 479 589  347 346 
Rice  5 34.7 20.8 36.9     
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Food Group  Iodine in dry food (µg/kg)  fresh food (µg/kg) 
 n Mean ± SD Median P95 %1  Mean Median 
         
Rice, processed 7 600 245 644     
Baked confectionery 13 245 260 148 741  206 126 
Pasta  9 39.3 45.9 10.8     
Pasta containing whole egg 6 155 100 163     
Breakfast cereals  10 42.4 51 22     
Grain flour 10 35.7 11.2 36.6 47.0    
Potatoes  3 16 11 18   2.9 2.7 
         
Meat and proteins         
Fish, marine  30 2591 2490 1594 6550  649 416 
Fish, freshwater 17 375 436 205 1225  211 81.7 
Egg, whole egg 6 1607 330 1526   325 303 
Egg, industrial egg white powder 10 205 76.4 188 339    
Poultry 33 64.0 107 37.2 139  26.9 9.5 
Beef 42 61.4 91.9 28.8 189  26.9 8.6 
Veal 10 76.9 31.2 77.1 125  20.4 19.1 
Pork 11 35.8 7.3 36.0 46.1  10.7 9.7 
Game  7 33.8 1.5 32.7   9.1 8.5 
Horse 11 63.4 54.5 46.4 166  17.5 12.0 
Lamb 12 51.0 56.4 28.6 156  14.5 8.3 
Vegetarian alternatives to meat 17 109 120 70 345  44.7 31.0 
Sausages and processed meat 34 325 379 109 1093  179 48.4 
         
Dairy products         
Milk 1997, year-round value 2 20 855 323 792 1473  103 95.0 
Milk 2007, September, farm level 197 587 467 459 1497  70.4 55.1 
Milk 2011/12, Winter 28 915 257 967 1267  112 116 
Milk 2012, September 18 585 199 579 849  70.2 23.9 
Yoghurt  7 736 369 644   184 169 
Quark 6 803 582 513   183 169 
Cheese 2000, hard and semi-hard 17 545 298 454 1058  326 301 
Cheese 2000, fresh and soft 8 303 208 191   117 101 
Cheese 2011/12, hard, semi-hard 3 49 192 143 150 442  119 93.0 
Cheese 2011, fresh and soft 7      89.6 83.0 
         
Vegetables and fruits         
Root and tuberous vegetables 16 65.8 54.6 34.5 162  7.3 4.1 
Salads and leafy vegetables 23 228 184 152 557  11.0 7.1 
Fruit vegetables 18 128 202 43.8 549  9.3 2.4 
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Food Group  Iodine in dry food (µg/kg)  fresh food (µg/kg) 
 n Mean ± SD Median P95 %1  Mean Median 
         
Bulb and stem vegetables 8 50.6 30.5 34.9   4.8 3.2 
Legumes 5 64.6 37.8 62.9   12.6 7.3 
Canned and frozen vegetables 14 1351 1630 571 4787  109 110 
Nuts  9 236 119 252     
Fresh fruit  62 18.2 14.5 14.7 44.2  2.7 2.0 
         
Beverages         
Sweet soft drinks 13      16.1 8.0 
Mineral water 2000 16      12.3 5.0 
Mineral and drinking water 2012 4 9      1.5 1.1 
Green Tea, leaves 6 119 90.2 90.2     
         
Miscellaneous         
Ready meals, canned or frozen 13 518 279 580 975  137 103 
Ready meals, in PET trays 5 5 214 133 201   59.7 67.9 
Ready meal, fish in aluminum tray  1 3850  3850   1170 1170 
Pizza, fresh 7 324 92.5 280   159 144 
Dietary supplements 5 867 168 867     
Swiss honey 11 45.3 21.6 37.2 85.1  37.8 31.0 
Mushrooms, dry  6 249 106 242     
Mushrooms, fresh 6 120 96.3 108   12.8 11.0 
1 95 % percentiles are calculated when n ≥10 
2 large-batch samples from regional dairy factories 
3 average dry weight, calculated on the basis of the year 2000 samples  (38 %) 
4 not carbonated 
5 PET (polyethylene terephthalate) package foods to be reheated in a microwave oven 
 
4.5. Iodine in Food 
The most recent data on iodine concentrations in Swiss foods are compiled in a study by Haldimann et 
al., which includes analysis of major food groups (4). These data have been regrouped in Table 9 and 
are listed along with new and previously unpublished results. It is immediately clear that the richest 
sources of iodine in food are marine fish, bread, eggs, and dairy products. The mean iodine 
concentrations in other foodstuffs such as meat, vegetables and fruits are extremely low. Unlike 
humans or animals, plants do not require iodine. Therefore, the accumulation of iodine from soils is 
relatively poor as it merely reflects uptake from diffusion. Salads and leafy vegetables have somewhat 
higher iodine levels than other vegetables; however, the amounts of iodine are so minute that they are 
nutritionally insignificant. The same is true for fresh fruits. Fruits contain hardly any iodine at all, 
regardless of whether the origin is domestic or overseas. 
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The major natural food source of iodine is fish. Marine fish have much higher iodine content than 
freshwater fish because plankton accumulates iodine from the sea and serves as a food source for 
marine life. Consequently, native Swiss fish do not contain high levels of iodine. The iodine content of 
the flesh of fish is therefore in contrast to that of animals. It can be seen from comparison that eggs 
have a much higher content than poultry – indeed studies have shown that iodine supplementation of 
chicken feed enriches iodine content of eggs, but not of the meat (14). Similarly, the content of red 
meat is much lower than the content of dairy products. Interestingly, game has a similar level to both 
red meat and poultry, indicating that iodine ingested from “artificial” feed is not accumulated in muscle 
tissue. In pigs, only moderate dose-dependent iodine increases in edible tissues to varying feed 
supplementations have been observed (15). 
4.5.1 Bread 
Bread is a substantial dietary source of iodine in the Swiss diet. However, like most other plant 
products, grain does not derive much iodine from the soil. Thus, the high iodine content of bread is 
attributed to iodized salt, which is added to the dough prior to baking, as confirmed by our analysis. A 
wide variety of breads, including many regional specialties, are typical in Switzerland. The level of 
iodine concentration, however, does not depend on the type of bread. Since bread is a potential food 
vehicle for iodine fortification, we made an assessment of iodine stability during processing. We 
analyzed two samples of bread. Regular bread doughs, along with all the original ingredients and the 
resulting bread samples were obtained from bakeries. When the low iodine content of flour is 
considered, it is clear that the iodine contained in bread has iodized salt as its source. For one type of 
bread, a loss of 25 % was determined, for the second, 18 %. This is comparable to the figure cited by 
the WHO of an expected 20 % loss (16). Fielderova observed an even higher retention of >96 % 
iodide in bakery products (17). Iodine measurements of recent bread samples (Table 9) indicate that 
the level has not decreased over the last ten years (pt; 0.05 = 0.06). Thus, the Swiss bread production 
practice that amounts to an average content of 1.85 % iodized salt has not changed (18). The bread 
market in Switzerland can be divided into that which is produced either industrially or in commercial 
bakeries; imported bread is negligible. 
4.5.2 Milk 
The iodine content of cow milk constitutes a considerable part of the iodine intake in humans. 
However, the high iodine content of milk originates largely from cattle feed and has been shown to 
vary strongly (5). Most of the cow fodder is plant matter, which varies greatly in composition and water 
content. As a rule, feeds of plant origin are poor in iodine and so it is added to meet the requirements 
of the dairy cows. Supplementary iodine in feed increases milk iodine concentration and this 
relationship has been established in dose-response studies (19). It is, however, possible that 
increases in milk iodine may be due to factors other than feed intake levels. Increased milk iodine due 
to teat dips have been reported (20). In Switzerland, iodophors as disinfecting agents are used mostly 
in post-milking dips (21) and so do not add appreciable amounts of iodine to the bulk milk (22).  
The natural or background iodine concentration of milk varies with the time of year, concentrations of 
iodine being typically higher in winter months. Previous studies in Switzerland have consistently 
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demonstrated a considerable seasonal influence on the iodine content of raw milk. Schällibaum (23) 
presented several sets of monthly milk iodine values collected over the year. The lowest values 
occurred from May to October, whereas peak concentrations were found in February and March. In 
summer, when the dairy cows graze on pastureland, milk iodine concentration is significantly lower 
than in winter, when they are kept in the barn and given feeds fortified with iodine. Dairy cowherds that 
are kept indoors all year round tend to produce milk with higher iodine content (24). In addition, dairy 
cows produce less milk in the winter, causing a concentrating effect on iodine in the milk.  
Apart from the seasonal effect, the relative amounts of iodine entering milk can vary considerably from 
farm to farm. Differences are attributed to cow race, lactation stage, and feeding practice, i.e. the use 
of iodine supplementation. To address this point, we analyzed samples of raw milk that were taken 
directly from dairy farms all over Switzerland. The sampling was done on a single day in mid 
September 2007 to exclude seasonal fluctuations. Figure 5 shows the distribution of iodine in raw 
milk. The distribution represents a snapshot of milk iodine at a time at which the concentrations begin 
to increase again to the winter levels, so allowing a comparison of the variability of values between 
different farms. The mean value (± standard deviation) was 70.4 ± 56.0 µg/l (geometric mean 
54.1 µg/l). In addition, a year-round distribution of milk iodine was simulated based on previous data, 
yielding a considerably higher mean value of 103 ± 38.8 µg/l (geometric mean 96.2 µg/l).  The smaller 
standard deviation reflects the narrower distribution of iodine concentrations in summer milk attributed 
to the lower iodine content in summer feed rations. 
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Figure 5: Histogram of iodine concentrations in raw milk sampled directly from Swiss dairy farms on 
19th September 2007. The solid line represents the fitted lognormal distribution. The broken line 
represents a simulated distribution for the year-round iodine milk concentrations based on previous 
distributions of iodine concentrations (summer and winter), which give both the range of values that 
the variable could take, and the probability of occurrence of each value within the range. 
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A post-study evaluation of data provided for a comprehensive milk study (5) was made to assess the 
influence of milk processing. After adjusting for the effects of season and interaction between milk 
processing, there were no statistically significant differences between the iodine concentrations of 
whole and semi-skimmed milk that were either normally pasteurized or ultra-heat treated (p = 0.589). 
There are indications that the amount of iodine in milk has changed significantly in recent years. 
Compared to the winter-half year value of 1997 (175 ± 79.3 µg/l), milk iodine in recent samples from 
winter 2011/12 has decreased (pt; 0.05 = 0.003), but still reflecting higher concentrations in winter 
(Table 9). In a comparative study, the contents of iodine in processed milk from nine European 
countries were measured (25). In the summer half-year, the Swiss iodine concentration in milk was 
90.3 ± 14.0 µg/l, which is a value that is higher than previously reported results (on average 30.7 ± 
6.7 µg/l) corresponding to the respective period (5). However, according to the European study 
Switzerland ranked among the countries with the lowest milk iodine levels. 
4.5.3 Cheese 
For years, the application of iodized salt has been favored to improve dietary iodine supply. Salting is 
a significant factor in the cheese making process, which is done either by immersing the cheese in 
brine for some time or by rubbing salt on its surface. The manner in which salt diffuses into the curd 
mass creates a concentration gradient inside the cheese. The salt penetrates from the outside and 
progressively reaches the center of the cheese. As time passes, the salt concentration tends to even 
out; however, depending on the type of cheese a gradient may still persist for an extended period. The 
diffusibility of iodine as iodide is completely different to that of sodium chloride; iodine is concentrated 
predominantly in the peripheral layers and the subsequent diffusion to the center can be inhibited by 
interaction with the proteins of the cheese matrix (26). In a comparative diffusion study with iodized 
and non-iodized salt, identical hard cheese samples of the Gruyère type were prepared in both ways 
(6). After a storage and ripening time of seven months, iodine was analyzed from different locations in 
the cheese wheel: crust, below the crust and center. There was no significant difference in iodine 
concentration between the two Gruyère samples prepared with iodized and non-iodized salt at the 
locations below the crust and in the center. Only in the crust itself had iodine accumulated in the 
Gruyère cheese that was made with iodized salt. It can be concluded that the use of iodized salt in 
brines has no effect on the iodine concentration of hard cheese. For this reason, it may not be 
necessary to utilize iodized salt in all hard cheese production processes because consumers normally 
cut away the crusts. Conversely, soft cheeses such as Camembert show a completely different 
picture. The application of iodized salt results in a clearly increased cheese iodine concentration, even 
though a difference in concentration between the peripheral and core layers may still exist.  
We monitored the fate of iodine during soft cheese production in all intermediate stages of Camembert 
production (Figure 6). The respective samples were obtained from a producer. The change of the 
iodine concentration (dry matter) in each step is illustrated in Figure 6. A slight decrease in iodine 
concentration occurred during the milk thermalization process. However, a large fraction of the milk 
iodine is lost because it partitions into the whey, which is separated from the protein coagulum. After 
the raw Camembert was immersed in brine, the iodine concentration rose above the initial milk value. 
Subsequently, some losses were observed during the ripening period. In addition, the starting milk for 
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the Emmental making process and the final cheese have been measured. The iodine data are overlaid 
in Figure 6 showing the fundamental differences between hard and soft cheese production. The iodine 
concentration in the final cheese is much lower than in the starting product. Apparently, immersion in 
brine with iodized salt did not have much of an effect on the iodine concentration in the Emmental 
cheese type. Even though the final salt concentration in Emmental cheese is comparatively low, the 
measurements confirm the fact iodine does not penetrate deeply into hard cheese. A similar but less 
extreme pattern of behavior has been observed in half-hard cheese, however, with iodate for brine 
salting (27). 
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Figure 6: Iodine concentrations in consecutive cheese production stages and the effect of salting with 
iodized salt. The black dots denote iodine soft cheese (Camembert) and the white dots denote iodine 
hard cheese (Emmental). The dotted line illustrates the concomitant selenium concentration in the soft 
cheese production in comparison to iodine. 
 
On the whole, producers no longer use iodized salt, as is illustrated by the decrease of the iodine 
concentration in the cheese samples from 2011 (Table 9). In particular, the iodine levels in hard and 
semi-hard cheeses were much higher ten years ago. However, the results are in contradiction to the 
above-mentioned diffusion studies (6;26;27). If the transport mechanism was diffusion, an equilibrium 
should be established with a constant concentration. Obviously that was not the case as the 
concentrations were much higher in the outer zones. Moreover, it is unlikely that the high values 
observed in the year 2000 are due to high milk levels because all of the samples were taken at the 
same time of year. The protein matrix of cheese is relatively loose and porous. Iodine moves freely 
along the cheese macro pores, whereby it is also interacting with the bulk material, in which it is 
trapped in the protein matrix. The ratio between trapped and free iodine depends on the proteins and 
also on the salt concentration. For this reason, the structure of cheese plays a critical role in the 
mechanism of iodine transport. 
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4.6. Food consumption and dietary intakes 
A rough estimation of dietary intake for the population can be calculated from food consumption 
statistics (28) and the reported iodine content of the various food groups (4). A comparison of these 
data can be seen in Figure 7, which shows the average iodine intake superimposed on the values of 
average iodine content of a particular food group. We can immediately see that the highest 
contribution to our general diet is from (the salt in) bread, although it itself is not the richest source of 
iodine. Fish, the highest natural source of iodine contributes far less, but still significantly, to our diet. 
The average daily intake calculated from food consumption data is approximately 140 µg. It should 
however be noted, that this value was calculated using the iodine content of foodstuffs as determined 
by Haldimann et al. in 2005 (4) and it will not be accurate if the iodine content of food has altered over 
the years. This gives only a general picture for the population as a whole, there is obviously a great 
variation in the diet from person to person and trends in nutrition are changing all the time. There are 
differences between the diets of men and women, families and people living alone, families with a stay 
at home parent and those with working parents etc. Women for example tend to eat more fruit and 
vegetables than do men (29). An adult following the dietary recommendations of the Swiss Society for 
Nutrition and the Federal Office of Public Health (30) will have an average daily intake of 
approximately 145 µg of iodine, which meets the requirements as recommended by the WHO  
(Table 10). 
0
10
20
30
40
50
60
0
500
1000
1500
2000
2500
Av
er
ag
e 
da
ily
 io
di
ne
 in
ta
ke
 (µ
g)
Av
er
ag
e 
Io
di
ne
 c
on
te
nt
 (n
g/
g)
Average I content
Average I intake
 
Figure 7: Average iodine content in various food groups and the resulting contribution to the dietary 
iodine intake. 
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Table 10: Daily iodine intake calculated from the Table 1 and the recommendations (selection, portion 
and portion size) for healthy, tasty eating and drinking for adults. 
 
No of 
portions 
Portion  
size 
water  
content 
RDA  
dry weight 
Iodine content 
of food 
Iodine per  
portion 
Total average daily 
iodine intake 
   (g) (%) (g) (ng/g) (µg) (µg) 
        Fruit/ Vegetables 5      2 
3 vegetables 3 120 91 10.8 47 0.5  
2 fruit 2 120 83 20.4 18 0.4  
        Starch 3      41 
bread  125  125 469 58.6  
pulses  100 91 9 65 0.6  
Potatoes  300 81 57 16 0.9  
pasta  75  75 80 6.0  
rice  75  75 35 2.6  
        Protein sources 1      31 
fish  120 75 30 2110 63.3  
meat  120 72.5 33 53 1.7  
eggs  157.5 80 31.5 1625 51.2  
fresh cheese  200 55 90 473 42.57  
hard cheese  60 36 38.4 473 18.16  
tofu  120 58 50.4 128 6.45  
        Nuts 1 30  30 218 6.54 7 
        Dairy products 3      64 
Milk  200 82 36 690 24.8  
Yoghurt  180 72 50.4 670 33.8  
fresh cheese  200 55 90 211 19.0  
hard cheese  60 36 38.4 205 7.9  
         Total           145 
 
The National Health Survey of 2002 shows that 61% of the population eat fish at least once a week, 
29% less often and 10% never eat fish. Young people (ages 15-24 years) eat the least, only 50% eat 
fish once or more a week. Socio-economic group also influences diet. It has been shown that people 
with a higher level of education and a higher income eat more fish. A geographical difference is also 
seen between the language regions of Switzerland: 78% of people living in the French-speaking part 
of the country eat fish once a week compared to 72% in the Italian-speaking region and 56% in the 
German-speaking regions. Foreigners (71%) eat more fish than do Swiss (59%). From these data, we 
can conclude, that although fish is a rich source of iodine, there is a significant part of the population 
for whom this is not the case.  
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Another statistic that must be treated with care is the amount of milk consumed per person. Again, the 
survey of 2002 shows polarized attitudes to milk consumption: 36% of the population as a whole 
drinks milk daily, while 38% never drinks it. However, it should be noted that, in general, children drink 
much more milk than adults. Men are more likely to drink milk than women. More milk is drunk in rural 
areas compared to towns and cities. For milk, there is little difference between the language regions. 
The higher the educational level and income, the less milk is consumed. Other dairy products are 
consumed daily by the vast majority of the population (98%) and no great difference is seen between 
men and women (29).  
The consumption of fast food, ready meals and processed foods is on the increase. With the 
increasing numbers of working parents, commute times, and working hours, more and more people 
are opting to eat from fast-food restaurants or from a limited range of pre-prepared foods. Young 
people are more likely to opt for such sustenance. 54% of people aged 15-24 years eat fast-food once 
a week, 32% aged 25-34 years, 19% of 35-44 year olds, dropping to 3% of pensioners (29). Indeed, 
8% of the Swiss population states that they never cook (31). The ready meals and ready-made pizzas 
analyzed show high iodine content (Table 9). It should be noted however that these pizzas were 
sourced from a Swiss bakery and so were made with iodized salt.  
4.7. Vegetarianism 
As shown in Table 9, fish, eggs and dairy products can be good sources of dietary iodine and 
restricting intake of these can lead to inadequate iodine intake, particularly if the individual does not 
use iodized salt. The iodine content of plants is dependent on the soil in which the plant grows; in 
many countries, including Switzerland, this is low and so insufficient iodine is harvested from the diet. 
A study in Germany showed that people following a strict vegetarian diet are at risk of iodine 
deficiency and this risk is augmented when iodization of processed foods is restricted due to 
legislation (32). 
4.8. Effects of cooking 
There are few studies on the effect of the cooking process on iodine in foods. Iodine loss depends on 
the type of iodine present in the food. Switzerland for example, uses iodide in iodized salt whilst iodate 
is preferred in other countries. One study reported the manner of cooking foods (frying, baking or 
steaming) is largely irrelevant in terms of iodine losses (33), but the amount of iodine lost is dependent 
on the cooking utensils used and the presence of other ingredients such as reducing sugars, food 
additives and acidulants. In contrast, studies on meatballs in Poland have shown that iodine loss 
varies greatly with cooking method. In this study, meatballs were made with iodized salt and by 
cooking in hot air rather than frying; only 5.5% iodine was lost as compared to 31.7%. Steaming vs. 
boiling showed losses of 42.9% and 64.9% respectively (34). In another study, a figure of 25.1% is 
quoted for a loss of iodine from a steamed meatball (35). 
The majority of iodized salt used in the home is in boiling water e.g. for the cooking of pasta, rice and 
potatoes. It has, however, been shown that these foodstuffs do not take up iodine from the water to 
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any great extent (36). Hence, this is not reliable as a source of iodine in our diets and so increasing 
the iodine content of salt available in the household will have only a limited effect on increasing iodine 
levels in the population as a whole. It is the use of iodized salt in processed foods that plays the 
determining role.  
4.9. Recommendations 
• Public health recommendations and dietary guidelines now encourage people to reduce their 
salt intake for cardiovascular health, and this could have a detrimental effect on the iodine 
levels of the Swiss population, as fortified salt is the main dietary source of iodine. In addition, 
the use of iodized salt by Swiss households and the food industry is voluntary. Also, changes 
in industrial practices and trade legislation can reduce dietary iodine supply. For all of these 
reasons, continued monitoring of iodine concentration in food, together with surveys of the 
population status, remains necessary in Switzerland. 
• The consumption of commercially produced bread is widespread, and is the most important 
vector for iodine supply in Switzerland. However, bread contains relatively high concentrations 
of salt and is therefore a target for salt reduction. However, an increase in the salt iodine 
concentration could compensate for a decrease of the salt content in bread.  
• Cheese could be an important nutritional source of iodine in Switzerland. However, the current 
use of non-iodized salt in its production because of labeling and export issues has reduced its 
contribution to iodine intakes in the population. Although not feasible for many producers, for 
cheese that is sold only on the domestic market, iodized salt, labeled as such, should be used 
instead of common salt.  
• Iodized salt consumed from home-cooked food contributes only a small proportion of the total 
iodine intake since most of salt consumption comes from processed foods. Therefore, it is 
critical that the Swiss food industry continue to use iodized salt in their products. To achieve 
this, continued advocacy toward the food industry from the Swiss government and other 
concerned groups is important.  
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5.1. Summary 
In Switzerland, salt is an effective vehicle for iodine fortification and is a major contributor to dietary 
iodine needs. Although iodine intake remains adequate in school children and pregnant women, iodine 
intakes are at the lower end of the optimal range. Moreover, the iodine intake in lactating women and 
weaning infants in Switzerland is borderline low. Use of iodized salt by households remains high, at 
greater than 80%, but use of iodized salt in industrially processed foods appears to be decreasing. 
Because most salt intake in Switzerland comes from processed foods, the use of iodized salt in all 
processed foods needs to be strongly promoted. The strategy to reduce salt intake is not in 
contradiction with the salt iodization program; these two important public health policies can be 
complementary but it is imperative that they be integrated. A reduced salt intake will require 
adaptations to the present Swiss iodine intervention strategy by: 1) ensuring high penetration rate of 
iodized salt in food production; and 2) adjusting the iodine fortification levels in salt to compensate for 
the lower salt intake. Iodine status should be monitored on a regular basis in school age children, 
pregnant and lactating women and infants. For the latter two groups, if the iodized salt program cannot 
provide adequate iodine intakes in the future, alternative intervention strategies will need to be 
considered. An effective iodized salt program in Switzerland that ensures adequate iodine for all age 
groups will require a joint effort of all partners including the Swiss Federal Office of Public Health, salt 
industry, food producers, academia, health professionals and consumer organizations.  
5.2. Global Perspective 
5.2.1  Introduction 
The strategy to control iodine deficiency with iodized salt has been remarkably successful, in 
Switzerland and worldwide. Iodized salt is available in households of 71% of the global population, up 
from 20% in 1990 (1). Switzerland was one of the pioneer countries to fortify salt with iodine already in 
1922 and the Swiss voluntary salt iodization strategy is often used as an exemplary model for other 
programs (see Chapter 3 of this report) (4, 5). But despite extensive national and global achievements 
in the control of iodine deficiency, many industrialized countries are lagging behind. More than one 
third of the iodine deficient countries are in the industrialized part of the world, eleven of them are 
European (3). In countries like U.K., Australia and New Zealand the iodine intake has deteriorated in 
the recent years and iodine deficiency reappeared (10-14). This is an apparent paradox as the overall 
salt intake in most countries steadily increased to levels far above the recommended salt intake (16). 
Falling iodine intakes is a worrisome trend, indicating that a large proportion of the salt consumed may 
not be fortified with iodine. Even if iodized salt for household use is available in most industrialized 
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countries, the food industry is partly reluctant to use iodized salt and much of the salt used in food 
production is not iodized. A recent study from Germany indicates that decreased iodine status may be 
attributed to the low use of iodized salt in processed foods (17). This chapter focuses on the 
importance of the use of iodized salt in the food production to maintain adequate iodine status in 
industrialized countries. The present situation of iodized salt use by the Swiss food industry and the 
potential consequences of public health activities for sodium reduction on iodine status in the Swiss 
population are discussed. 
5.2.2 Iodized salt in processed foods 
Iodized salt is generally the main dietary source of iodine in the industrialized part of the world (5, 17). 
WHO recommends salt to be fortified with iodine at a level of 20-40 mg iodine per kg salt, based on an 
estimated average salt consumption of 5-10 g/day in adult populations (18). Milk and dairy products 
are other rich dietary iodine sources (19-23), particularly important in children (17, 21, 24, 25) and in 
countries without iodized salt (25, 26). Salt water fish and seafood have high natural iodine content 
(27), but their contribution to the overall dietary iodine intake is modest (17, 25). Detailed discussion of 
the iodine content of Swiss foods can be found in Chapter 4 of this report. 
The dietary salt intake in the general population is high (8-12 g/day) in most parts of the world (28) and 
is 2-3 times the recommended 5 g per day (16, 29, 30). Iodine added to household salt generally used 
to be the main iodine source at times when most meals were prepared at home. However, the food 
consumption patterns in industrialized countries have largely changed and discretionary salt added 
while cooking or eating a meal is now estimated to only 11% of the total salt intake (31). Adults 
consuming on average ca. 10 g/day have an iodine intake from iodized household salt of about 20-
40 µg/day, far below the daily dietary iodine requirement (32, 33).  
The main part of the total salt intake comes from salt used in the food production, ready-made foods 
obtained from a store or a restaurant (16, 31, 34). Foods like bread and processed meat have 
particularly high salt content and contribute the most (35-37). The salt intake from processed food 
generally increases with age and tends to be higher for males than females (14, 35, 37-40). The use of 
iodized salt in the food production is crucial to meet the iodine requirements of the population in 
industrialized countries. Chapter 4 of this report includes a discussion of the use of iodized salt in 
Swiss foods. Nevertheless, only few countries mandate salt used in the food industry to be iodized (5, 
41, 42). In most countries it is up to the producer to choose whether to use iodized salt in the food 
production or not. A recent survey among food companies in 39 countries shows that use of iodized 
salt in the food production varies substantially between countries and between companies within the 
same country (43). The same is true for foods obtained from a store or a restaurant. A study of iodine 
content in fast foods in the United States reports that the fast food chain Burger King used iodized salt, 
whereas McDonald’s, Wendy’s, and Taco Bell did not (44).  
The reason for the reluctance from the food industry to use iodized salt appears to mainly be lack of 
awareness of the importance of iodine in nutrition and of salt as a fortification vehicle for iodine (43). 
The hurdle is not primarily cost, as the price difference between iodized and non-iodized salt is 
negligible in most countries (43). Trade barriers are other reasons for not using iodized salt in the food 
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production identified by food industry representatives, i.e. some countries prohibit the addition of 
iodized salt to processed foods, which may impact export (43). Consumers' skepticism about food 
additives and misconceptions that iodized salt may change taste or color in food products are other 
constraints. Additional factors listed by the food industry are increased production costs if some foods 
are produced with iodized salt and other are not, lack of resources and technical capability, lack of 
enforcement, instability of iodine, potential equipment and process overhauls and competing priorities, 
although most of these reasons may be of minor importance for food producers in the industrialized 
world (43).  
Despite barriers, there are several good examples of how the food industry can contribute to ensure 
adequate iodine intakes in the population. Denmark, Australia and New Zealand are now mandating 
the use of iodized salt in bread production (49-51). In Denmark the law was introduced in 2000 and 
iodine status is now adequate in the general population (49, 50). In Australia and New Zealand the 
program was introduced in 2009 and recent local data now indicate that the iodine intake has 
increased and is adequate (52, 53). In the Netherlands and Belgium, the baking industry use iodized 
salt on a voluntary basis, enough to maintain adequate iodine intakes of the general population (54, 
55). 
Information on the iodine content in processed foods is limited. Food packages declare total salt 
content, but there are no uniform rules for declaring whether iodized salt has been used in the food 
production. Food composition databases generally contain information on the total salt content of 
foods, but they rarely specify if the salt used is iodized or not. Even if iodized salt is declared, there 
may be differences in salt iodine content between brands of the same product or even for the same 
brand sold in different countries. This makes it difficult to keep food composition databases up-to-date. 
A large multicenter study is underway to compare the contribution of salt from processed foods 
between countries, between food companies, and over time (56). Such data should be accompanied 
with information on the actual use of iodized salt in processed foods.   
5.2.3 Salt reduction strategies 
Dietary salt reduction initiatives to decrease the salt intake and reduce the risk of heart disease are 
now being launched around the world (28, 57-59). Consumer education and awareness campaigns 
are introduced together with activities aiming at the food industry to reduce the total salt content in 
foods. Salt reduction initiatives do not conflict with salt iodization strategies, if all salt used in food 
production is iodized and the iodine fortification levels are adapted to the actual average amount of 
salt consumed (60-62).  
The effects of reduced salt intake can be simulated with the help of statistical models (5, 54, 63, 64). 
Individual level data from food consumption surveys can be used in prediction models to estimate the 
habitual iodine intake from: 1) native iodine content in foods; 2) iodized salt added to industrially 
processed foods; 3) discretionarily iodized salt; and 4) iodine containing dietary supplements. The total 
iodine intake in a population can be estimated and the percentage of the population with adequate 
intakes can be defined based on the Estimated Average Requirement (EAR) cut-point method (65, 
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66). The nutrient intake is satisfactory when most individuals of the population (97-98%) meet the 
EAR, i.e. the acceptable proportion of inadequate intakes is 2-3%.  
The anticipated effect by different salt intakes or salt iodine levels can be estimated by varying the 
amount of salt consumed from different types of foods and altering the market shares of iodized salt-
containing industrially processed foods. Such simulation studies  have recently been conducted in the 
Netherlands, New Zealand and Belgium (54, 55, 63, 64). These show that a key factor to maintain 
adequate and homogeneous iodine intake in the population is to ensure a high use iodized salt in 
industrially processed foods. The Dutch study demonstrates that even when the salt intake is reduced 
(by 50%) to the recommended intake level of 5-6 g/d, mandatory use of iodized salt in bread, at the 
present fortification level of 58 mg/kg salt, and of discretionary salt at a level of 20 mg/kg, maintains 
adequate iodine intakes in the general population (63). Simulation models like this may be useful 
when planning the anticipated effects of reductions in salt intake. A limitation with prediction models is 
that they are largely based on dietary assessment data of and that the total salt intake and the iodine 
intake from iodized salt may lack precision(67-69). 
The recommended fortification levels of 20-40 mg iodine per kg salt levels are safe up to salt intakes 
of around 25 g/day (70).  But, commercially available iodized salt may contain iodine in the range of 
15-80 mg iodine per kg salt (5, 41). The optimal window for iodine intakes in the population is relatively 
narrow. On one side are pregnant and lactating women with high iodine requirements and on the other 
side stands the risk of high intakes in other subgroups. The individual iodine intake should not exceed 
600 µg/day and the population UIC should not exceed 300 µg/L (71, 72). Thus, before adjusting the 
iodine levels in iodine fortification programs factors such as the foods consumed, salt and iodine food 
sources, iodine nutritional requirements of the population and vulnerable subpopulations (young 
children, pregnant and lactating women) have to be considered to ensure iodine intakes which cover 
all groups and do not pose a risk of high intakes in other groups (60, 62). An Expert Committee 
convened by the Pan American Health Organization on Optimizing Dietary Salt and Iodine is currently 
developing a framework for such activities that could serve as model for other countries (62). 
5.2.4 Vulnerable population groups 
It is unclear whether iodized salt supplies enough dietary iodine for all population groups including 
pregnant women, lactating women and their breastfed infants with higher iodine requirements (63, 64). 
In some countries, pregnant and lactating women have low intakes even when SAC and the general 
population have optimal intakes (73-75). The iodine intake of breastfed infants relies solely on the 
iodine concentration of breast milk, which, in turn, reflects the mother’s iodine status (76). The iodized 
salt program gets to the infants only indirectly through the breast milk. Lactating women have high 
iodine requirements due to the iodine transferred to the breast milk and may be at risk of iodine 
deficiency, despite adequate intakes in the general population (9, 33). 
Several countries, with and without iodine deficiency, have recognized this fact and are recommending 
iodine supplementation to all pregnant and lactating women, e.g. Australia and New Zealand with mild 
iodine deficiency (77) and the U.S. with overall adequate iodine status (78-80). The recommendations 
in these countries state that all prenatal vitamin/mineral preparations should contain 150 µg of iodine 
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and that daily iodine supplementation should continue through lactation (77-80). However, it should 
also be emphasized that the scientific basis for the recommended daily iodine intake in lactating 
women and young infants, the criteria to assess their iodine status and the present recommendation to 
provide targeted iodine supplementation is poor. 
In countries with iodized salt as main strategy to control iodine deficiency, attention must also be paid 
to weaning infants. Infants are at high risk for iodine deficiency, because their iodine requirements per 
kg body weight are much higher than at any other time in the life cycle (33, 81, 82). Salt and salty 
foods should be avoided during the first year of life (83). Data on iodine status in weaning infants is 
limited, but recent studies indicate that the intake may be low, particularly infants not receiving iodine-
containing infant formula milk (9, 63, 76, 84). Chapter 3 of this report contains data on the iodine 
status of Swiss infants and discusses the effects of different feeding practices.  
5.2.5 Monitoring 
All iodine intervention programs require careful population monitoring of the iodine status, as both 
iodine deficiency and iodine excess may have adverse health effects. Monitoring of iodine status will 
become particularly important as salt reduction strategies take effect. Iodine status in the population is 
monitored by measure UIC in a spot urine sample (72). School-aged children have traditionally been 
the main age group for iodine surveys, primarily because they are easily accessible through school 
surveys (3). However,, with modifications in iodine intakes, the focus for monitoring of iodine status 
should be shifted to also include risk groups like young children, women of reproductive age, 
pregnant- and lactating women (85). Monitoring should preferably also include periodic assessment of 
thyroid function (81).  
5.3. The situation in Switzerland 
5.3.1  Legislation 
The Swiss legislation regulates salt sold for human consumption to be iodized on a voluntary basis, 
including household salt and salt used in the food production (86-88). The federal decree allows iodine 
fortification in the range of 20-30 mg/kg salt as iodide or iodate (87). Iodized salt has to be clearly 
labeled on the salt package and the producer may use the health claim “Sufficient iodine intake 
prevents goiter” (87). It is obligatory to declare the use of iodized salt in processed foods or other food 
products (87, 88). The policy is regulated on the national level and there is no common European 
policy. 
5.3.2 Household consumption of iodized salt 
Three recent national studies conducted in 6-12 years old children, adults (≥15 years), and pregnant 
women assessed the consumption of iodized salt in Swiss households (9, 89). Iodized salt is used in 
three out of four homes of school children and pregnant women, but is only used by one third of 
adults. In the 2009 UIC study in children (n=916) household salt samples were collected in a sub-
sample of 266 randomly selected homes and the iodine content was measured (9). Eighty percent 
(n=213) of samples had iodine concentrations >15 mg/kg and the median (range) iodine concentration 
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of those samples was 19.8 (15.1-33.0) mg/kg. In the 2009 UIC pregnancy study (n=648) and the 
2010-2011 Swiss Salt Survey (SSS) (n=1448) participants were asked to fill out a questionnaire 
indicating what type(s) of salt they generally use at home (9, 89). The percentage of pregnant women 
who reported use of iodized salt was 74% (9). In the SSS only 36% reported that the salt they use is 
iodized and 34% reported that they use non-iodized salt (89). The remaining participants in the SSS 
used "spicy salt" or did not know what type of salt they have at home. The consumption of iodized salt 
was 42% in the German-speaking region, higher than participants from the French and Italian regions 
(p < 0.001). The proportion of iodized salt use is surprisingly low, much lower than earlier reported (8). 
The data should be confirmed in future studies.  
5.3.3 Salt production and sales of iodized salt 
The leading salt producer in Switzerland is the Schweizer Rheinsalinen AG (Pratteln, Switzerland), a 
company owned in part by 25 Swiss cantons. The company produces both iodized and non-iodized 
salt for the domestic and international market. Sales figures from 2011 indicate a worrisome trend with 
an increasing proportion of the sales of non-iodized common food grade salt, ca. 50% of all salt sold is 
not iodized, up from 8% in 1986 (Personal communication, Stefan Trachsel, December 2012) 
(Figure 8 and Figure 9). However, it is not known what proportion of this salt that is actually sold on 
the Swiss market. It is plausible that a large portion of the total amount of the salt produced is exported 
to food companies outside Switzerland.  
 
Figure 8: The ratio of iodized vs. not iodized common food grade salt sold in sacks from the Swiss 
Salt Works has declined over the period 2006-2011. 
 
The overall sale of iodized salt (sold in 0.5 kg, 1 kg, 12.5 kg and 25 kg packages) has been stable 
over the last 30 years. The total amount of iodized salt sold in cans and smaller packages (0.5 kg and 
1 kg), likely mainly for households on the Swiss market, decreased over the last 10 years. 
Nevertheless, the proportion of the salt sold in small packages that is iodized (out of the total amount 
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of salt produced) remains stable at 93%. The part of the iodized salt sold in 12.5 kg and 25 kg 
packages, likely salt sold to restaurants, institutional kitchens, and food producers, has increased 
10 fold since the beginning of 1990's. Still, the total amount of iodine used in the overall production 
went down from 1.36% to 1.11% relative to the total salt production, indicating a decreased overall 
production of iodized salt. 
 
 Iodized 15-20 mg/kg with fluoride Iodized 15-20 mg/kg Iodized 7.5-10 mg/kg  Not iodized 
Figure 9: Total sales (tons) of common food grade salt by the Swiss salt works (1996-2011) 
 
5.3.4 Food industry 
The Swiss food industry use iodized salt in the food production on a voluntary basis. The information 
on the iodized salt in processed foods is incomplete and data on the actual penetration rate in Swiss 
food production is limited. Many cheese producers have discontinued the use of iodized salt, as 
described in the chapter by Haldiman and Stalder (90). 
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The reasons for the relatively low use of iodized salt by the Swiss food industry are largely unknown. 
One reason may be legislative differences between countries in Europe, although the legislation on 
iodized salt in the neighboring countries Austria, Germany, Italy and France promotes iodized salt for 
food production (17, 41, 42, 91-93). The legislation in other European countries varies, from no 
legislation, voluntary to mandatory salt iodization (41). The use of iodized salt by the food industry in 
Europe is generally low.  
5.3.5 Salt intake and coordination of public health messages on salt reduction and 
iodized salt use 
The dietary salt intake in Swiss adults was assessed in a recent nationwide survey of 1448 randomly 
selected individuals (≥15 years) using 24-hour urine collections (89). The mean (± SD) salt intake was 
7.8 ± 3.3 g/24 h in women and 10.6 ± 4.2 g/24 h in men. The intake was clearly above the international 
recommendation of 5 g/day and only 22% of women and 6% of men had urinary salt excretion below 
5 g/24 h. The salt intake appears to have remained at the same level over the past 20 years. A 
longitudinal study of 13'335 adults (35–74 years) in the Geneva area reports a stable salt intake of 
7.8 g/day in women and 10.5 g/day in men over 12 years (1993–2004) (94). 
The Swiss Federal Office of Public Health (FOPH) launched a nationwide strategy in 2008 to reduce 
the dietary salt intake during the 4-year period 2008-2012 (95). The intermediate goal of this strategy 
is to decrease the overall salt intake to less than 8 g/day by the end of 2012 and the long term goal is 
to stabilize salt intake to less than 5 g/day (30, 95). Strategies for how to reduce the salt content in 
processed and restaurant foods were proposed and evaluated in a recent consumer tests study by 
Zülli and Allemann (96). The investigators propose minimum salt content levels for 4 food categories, 
i.e. bread and baked goods, meat products, ready-to-serve meals and meal components as well as 
cheese and cheese products. These food groups, particularly bread, are major iodine sources in the 
Swiss diet (21, 90, 97). Reduced salt content in the priority food groups may lead to a reduction in the 
overall iodine intake. However, the information on the proportion of producers using iodized salt in the 
production of bread, meat products and ready-to-serve meals is limited. The immediate effect of a 
reduced salt content in these products is therefore difficult to predict unless this information is 
obtained. Since many cheese producers have discontinued the use of iodized salt (90), a reduced salt 
content in cheese will likely have small effects on the iodine intake.  
The use of iodized salt in the food production should be promoted for all processed foods to minimize 
the risk of a reduced iodine intake. If all salt used in food production is iodized (at present fortification 
levels of 20 mg/kg), a salt intake of 8 g/day will meet the iodine requirements of adults (33). Further 
future reductions in salt intake may require an increase in the iodine fortification level. 
International experience from other countries indicates that a salt reduction from currently 9.4 g to 
8.0 g per day per person may take longer than the intended 4-year period aimed for by the Swiss 
Federal Office of Public Health (98). However, a slow reduction in salt consumption and gradual 
changes in iodine intake is an advantage for population iodine nutrition. Studies from Denmark, where 
iodine fortification levels were gradually increased in small steps, shows that even small increases in 
the iodine intake reduces the prevalence of hyperthyroidism in the population, but may still slightly 
increase the risk of hypothyroidism and thyroid autoimmunity (99-101). The Danish groups 
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demonstrate that monitoring of thyroid status is an important part of the overall monitoring program for 
iodine nutrition.  
Most Western countries are now launching salt reduction strategies many  will face similar issues with 
regard to iodine nutrition. Exchange of experience between countries will be important. A sustainable 
reduction of salt consumption and maintained iodine status will be achievable only if all relevant 
stakeholders, including consumers, cooperate jointly and recognize both public health goals in a 
combined strategy.  
5.3.6 Vulnerable population groups 
The most recent Swiss national iodine survey reported 6 and 12 month old infants and their mothers 
are at risk of low iodine intake (9). (Please see Chapter 3 of this report for more details.) The iodine 
status of breast-fed infants was lower than in non-breast-fed infants, and weaning infants receiving 
iodine fortified infant formula had higher median UIC than those who did not. This raises concern that 
the present iodine intervention strategy may not entirely cover these target groups. Salt reduction 
strategies without changes in the salt iodine levels may further reduce the already low iodine intake of 
lactating women. Iodine supplementation to lactating women and iodine fortification of infant formula 
may therefore be important as an alternative strategy to meet their high iodine requirements. 
5.4. Recommendations  
• Research: a) Assess the use of iodized salt in the food production; b) Promote food analysis 
of iodine content in foods; c) Incorporate information on the native iodine content and the 
iodized salt content in Swiss foods in the Swiss Food Composition Database; d) Adapt the 
protocol of the upcoming Swiss National Nutrition Survey to incorporate salt and iodine intake 
so that the dietary data collected can be used in model analysis to predict changes in salt and 
iodine intake; e) Promote research to define the estimated average requirements for iodine in 
lactating women and young infants. 
• Technical support: a) Technical training and assistance to the food industry in establishing 
quality control sampling and analytical procedures, if needed.  
• Policy:  a) Encourage use of iodized salt by the Swiss food industry;  b) Promote declaration of 
iodized salt on food packages; c) Regularly evaluate the data on iodine intake, salt intake, 
iodine status and thyroid function obtained from the population monitoring to adjust the iodine 
levels in salt based on the population’s intake patterns if needed; d) Ensure appropriate iodine 
intakes in vulnerable groups, i.e. infants, pregnant women and lactating women; e) Evaluate 
the need for iodine supplementation of pregnant and lactating women. 
• Political commitment and legislation: a) Ensure that policy changes on iodized salt are done in 
close collaboration with Swiss Fluoride and Iodine Commission; b) Support coordinated 
European efforts to raise the priority of iodine nutrition on the political agenda in Europe and 
support a common EU policy for the voluntary use of iodized salt by the food industry, 
including the cheese-making industry. 
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• Partnership: a) Ensure continued participation of government partners, national agencies, 
nongovernmental organizations, salt producers, academia and the health-care sector in the 
Swiss Fluoride and Iodine Commission and; b) Give the Swiss Fluoride and Iodine 
Commission continued mandate to review information from monitoring activities for planning 
and promotion of collaborative work between the different sectors; c) Consider participation of 
food industry and consumer organizations. 
• Advocacy and communication: a) Promote the use of iodized salt in the food production and 
the households; b) Develop appropriate communication through mass media, the health 
system, food industry organizations, and other context specific channels to educate the public, 
salt producers and food producers about the importance of iodine nutrition and salt as a 
fortificant for iodine;  c) Provide support to the Schweizer Rheinsalinen AG to increase the 
demand of iodized salt from the food industry; d) Information campaigns of iodine nutrition 
should be combined with and integrated in salt reduction campaigns; e) Advocacy should 
combine messages on the benefits of salt reduction and adequate iodine intake; f) Potential 
critics from the public and the food industry should be anticipated and addressed before 
launching campaigns. 
• Monitoring: a) Maintain monitoring and control systems for food at the Cantonal level to 
ensure adequate salt iodine levels from salt production, food production to consumption; b) 
Maintain the periodic monitoring of iodine status (UIC) and thyroid function (thyroglobulin 
concentration) in school children and pregnant women; d) Maintain the neonatal TSH 
screening program; e) Introduce monitoring systems for assessing iodine status in vulnerable 
population groups, i.e. infants, women of reproductive age and lactating women.  
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